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 Gram-negative bacteria have developed various secretion systems. These 
secretion systems play important roles in maintaining communication with the 
environment and in inflicting pathogenesis on respective hosts. Among them, Type 
III (T3SS) and Type VI (T6SS) secretion systems have been identified as the major 
components of bacterial virulence. Recently, more attention has been drawn to this 
research area, as proteins within these secretion systems might potentially represent a 
novel line of antibiotic development.  
In this thesis, we aimed to gain structural insights into the novel secreted 
protein EvpP from the Type 6 secretion system of Edwardsiella tarda. EvpP is a 
unique protein found exclusively within the Edwardsiella species, which has no 
homologues among other genera. EvpP has been characterized as a non-stable protein 
which does not have a well-folded tertiary structure. Flexible regions with intrinsic 
disorder are well-known for their roles in mediating protein-protein interaction. 
Therefore we have mapped out the rigid and flexible regions of EvpP using three 
different approaches: limited proteolysis, nuclear magnetic resonance (NMR) 
backbone assignment and hydrogen-deuterium exchange mass spectrometry.  
 Limited proteolysis has shown a coherent pattern that the N-terminal half is 
more rigid than the C-terminal half. Trypsin-digested pattern further suggested 
another rigid region in a 4-kDa section within the C-terminal half of EvpP. We also 
obtained a relatively complete backbone assignment of EvpP using a stable mutant 
EvpP_P143T. More than 90% of the assigned peaks were located within the trypsin-
digestion boundary. In addition, NMR data have suggested a third rigid region, 
possibly near the C-terminal end, which was supported by the hydrogen-deuterium 
exchange mass spectrometry (HDX-MS) experiments. Heat maps plotted using both 
wild-type and mutant EvpP demonstrated that the linker region between the N-
terminal half and the 4-kDa section was the most flexible region throughout the entire 
viii 
 
protein. Finally, we investigated the interaction between EvpP and EvpC, which is 
another secreted protein of T6SS. Glutathione S-Transferase (GST) pull-down assay 
using GST-EvpC and EvpP has demonstrated that the C-terminal flexible region 
might be involved in their interaction; while NMR titration experiments have 
suggested a binding stoichiometry of one to one. These results may pave a way for 
better understanding of the structure and function of this novel secreted protein, EvpP.  
 The second chapter of this thesis aimed to optimize the boundary for the 
crystallization of a chaperone-translocator complex, AcrH-AopB from the T3SS of 
Aeromonas hydrophila. AcrH is a Class II chaperone for translocators AopB and 
AopD. The structures of Class I and Class III chaperones in complex with either 
effector or apparatus proteins have been determined already. However, no complex 
structure of a Class II chaperone with translocator has been reported. Using limited 
proteolysis with a combination of three proteases, thrombin, thermolysin and actinase 
E, we obtained a much shorter boundary of the complex AcrH∆C-AopB
61-264
 that 
could still bind each other tightly. Although this construct did not yield a high quality 
crystal; it nevertheless suggested a shorter AcrH binding region of AopB. The N-
terminal disordered region of AopB might have a novel function instead of being 
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CHAPTER 1, INTRODUCTION 
1.1 Secretion System 
1.1.1 A general introduction to bacterial secretion systems 
 Secretion, the term describing the dedicated transport or translocation of 
molecules from the interior of a cell to its exterior, is a universal process throughout 
all three domains of life. Bacterial secretion systems play important roles in 
pathogenesis, or virulence, as well as maintaining communication among bacterial 
cells or between bacterial cells and their host. Through this process, bacteria could 
adapt to the environment and gain invasion into its respective host cell. Up to now, 
great breakthroughs in this research field have shed light on the structure, topology 
and mechanism of various bacterial secretion systems. Inhibiting secretion seems to 
be a novel line of antibiotic development compared to traditional antibiotics, which 
aim to kill bacteria directly. 
1.1.2 Secretion in gram-positive bacteria 
 Secretion in gram-positive bacteria are more straight-forward than gram-
negative bacteria because gram-positive bacteria have a single plasma membrane and 
a thick peptidoglycan layer in their cell walls (Shockman and Barrett, 1983). 
Precursor proteins destined for secretion in gram-positive bacteria usually carry an N-
terminal signal peptide. Most of them are transported across the plasma membrane in 
an unfolded state by the general secretion pathway (Sec pathway, Karel et al, 2001). 
After this, the precursor gets processed and folds into its active form. Some secreted 
proteins carry C-terminal sorting signal peptides that will get cleaved by different 
sortase enzymes after crossing the plasma membrane. Sortase A cleaves the C-
terminal LPXTG sorting signal and anchors proteins to the cell wall (Ton-That, H et 
al, 1999). Sortase B cleaves the sorting peptide NPQTN or NPKTG (by sortase B 
homologues) and anchors haem scavenging factors (Mazmanian et al, 2002 and 
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Maresso et al, 2006). Sortase C cleaves the sorting signal LPNTA and anchors 
proteins to the envelope of spores (Marraffini and Schneewind, 2006). Aside from the 
general secretion pathway, two-arginine (Tat) pathway is also found in gram-positive 
bacteria. The Tat machinery recognizes an N-terminal sequence motif that is rich in 
basic amino acid residues (S-R-R-x-F-L-K) and transports proteins in its folded state. 
Proteins secreted by this pathway usually have large cofactors bound to it (Muller M, 
2005). In addition, Type VII Secretion system (T7SS) is found in some species of 
gram-positive bacteria. 
1.1.3 Secretion in gram-negative bacteria 
 Unlike gram-positive bacteria, the secretion systems in gram-negative 
bacteria are more complicated because gram-negative bacteria possess not only an 
inner plasma membrane, but an outer membrane as well. Although the general 
secretion pathway and Tat pathway were also present in gram-negative bacteria; 
proteins secreted by the above pathways (mostly with an N-terminal signal peptide) 
are usually transported into the periplasmic space. Therefore additional machinery is 
needed to further transport the proteins across the outer membrane or proteins can be 
transported from the cytosol directly to the extracellular milieu. Up to seven different 
types of secretion systems and several subtypes have been found in gram-negative 
bacteria. They include chaperone-usher pathway and six other pathways, namely 
Type I (T1SS) to Type VI (T6SS) secretion systems. The chaperone-usher pathway is 
responsible for the secretion and assembly of adhesive surface structures called 
fimbriae (Andreas and Gabriel, 2011). T1SS to T6SS transport a wide variety of 
molecules ranging from nucleic acids to proteins. The process of secretion also differs 
from one-step (molecules are transported directly from the cytosol to the extracellular 
space) to two-step (molecules are transported from the cytosol to the periplasm before 
being transported across the outer membrane to the extracellular space). Type III and 
Type VI secretion systems have been discovered to be the major components of 
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bacterial pathogenesis towards various hosts. Therefore, these two secretion systems 
will be further discussed in this thesis. 
 
Figure 1.1, Simplified view of the seven secretion systems. HM: host membrane; OM: outer 
membrane; IM: inner membrane; MM: mycomembrane; OMP: outer membrane protein; MFP: 
membrane fusion protein. Tseng et al. BMC Microbiology 2009 9(Suppl 1):S2 
 
1.1.4 Type III Secretion System (T3SS) 
 Type III secretion systems were first discovered in pathogenic Yersinia 
species, for its secretion of different Yop proteins (Michiels P et al, 1990). Since then, 
T3SSs have been found in both plant and animal gram-negative pathogens, some of 
which communicate with their host as mutualists. Similar to T1SS, T3SS is sec-
pathway independent, as effectors get secreted across both inner and outer 
membranes in a one-step process without a periplasmic intermediate. However the 
assembly of T3SS, which involves the transport of T3SS subunits to the outer 
membrane, may partly rely on the general secretion pathway. More than 20 subunits 
of T3SS have to be orchestrated to form a needle complex spanning both membranes 
and the periplasmic space. These genes are usually localized together in a plasmid or 
a chromosomal locus with some species possessing more than one copy of T3SS. 
T3SS also has secretin-like proteins, similar to those in T2SS. Some of these proteins 
oligomerize to form ring-shaped structures with central pores while some stabilize the 
needle-like complex formed by other components of T3SS (Gauthier et al, 2003).  
A typical T3SS usually consists of a basal body spanning both the inner and 
outer membrane of the bacteria, a needle complex that protrudes outwards from the 
bacterial cell surface and a translocon at the tip of the needle complex (Cornelis and 
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Van G, 2000). The T3SS needle complex is essentially formed by a single protein of 
small molecular weight. Such proteins have been identified in various organisms: 
PrgI in Salmonella typhimurium (Kimbrough and Miller, 2000), YscF in Yersinia 
enterocolitica (Hoiczyk and Blobel, 2001), MxiH in Shigella flexneri (Blocker et al, 
2001) and PscF in Pseudomonas aruginosa (Pastor, et al, 2005). These small proteins 
are supposed to polymerize and form a conduit for the transportation of effectors. The 
structures of some needle complex proteins have been solved: PrgI (Wang, et al, 
2007), MxiH (Deane, et al, 2006) and AscF (Yih W T, et al, 2008). They all form an 
anti-parallel two-helix-bundle joined by a loop turn consisting of the conserved 
residues [P-(S/D)-(D/N)-P]. 
 One striking feature of T3SS is its ability to secrete effectors directly into 
eukaryotic host cells. This is triggered by the direct contact of the bacteria with its 
host. Therefore T3SS is termed as “contact dependent”. At the tip of the injectisome 
that contacts the host cell surface, T3SS forms a “translocon” which consists of three 
subunits. Two of them have hydrophobic domains which are proposed to be inserted 
into host cell membrane, allowing effector translocation into host cell cytosol 
(Hakansson et al, 1996; Warawa et al, 1999; Faudry et al, 2006). The third subunit is 
hydrophilic and the assembly of the translocon is dependent on this hydrophilic 
subunit (Fields et al, 1999; Marenne et al, 2003). One well-studied translocon model 
involves the LcrV-YopB-YopD translocators of Yersinia enterocolitica; where LcrV 
is the hydrophilic subunit which forms a tip at the distal end of the injectisome. YopB 
and YopD are the hydrophobic translocators that are inserted into host cell membrane 
(Goure et al, 2005). The genes encoding the translocators usually localize together in 
a large operon. Within the same operon, there’s usually one gene encoding a small 
protein, which functions as the chaperone for the hydrophobic translocators, 
sometimes with another gene encoding a regulator protein of T3SS. Some of the 
effectors, such as YopE and YopT as an example from Yersinia species, may even 
carry anti-pore formation activity after being injected into the host cell (Viboud and 
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Bliska, 2001). Although direct secretion of effectors into host cell cytosol is a 
fascinating feature of T3SS, it is not universal to Type 3 secretion as many proteins 
secreted by T3SS do not translocate into host cells. 
One common feature of the T3SS translocator proteins is their possession of 
coiled-coil regions. A coiled-coil region usually comprises of two or more α-helices 
which form a bundle like structure. This structure is generally associated with 
increased flexibility; but important for protein-protein interactions with other 
members of T3SS or with itself (Anastasia D, et al, 2009). However, coiled-coil 
regions are not unique to translocator proteins. It has been found that HrpO from 
Pseudomonas syringae, a soluble apparatus protein possibly with ATPase activity, 
interacts with HrpE through the contact of the coiled-coil regions in both proteins 
(Anastasia D, et al, 2008). 
Effectors translocated into host cell cytosol via T3SS often carry out specific 
functions such as repressing host cell defense response or modulating its cytoskeleton. 
One well-studied model organism for such effector function is Shigella flexneri, a 
gram-negative bacterium that can cause shigellosis in humans. Among the subset of 
effectors delivered by the T3SS of S. flexneri, VirA was reported to trigger host cell 
microtubule destabilization by directly binding to the α/β-tubulin heterodimers (Sei Y, 
et al, 2002). This destabilization can cause local microtubule growth, which in turn, 
results in the induction of Rac1, a small Rho-GTPase involved in various pathways of 
actin cytoskeleton remodulation (Wittmann and Waterman-Storer, 2001). Thus, the 
invasion of S. flexneri will cause local membrane ruffling that allows further bacterial 
endocytosis. Apart from microtubules, actin filament is another major target of T3SS 
effectors for host cell cytoskeleton reorganization. IpgB1, also from S. flexneri, has 
been found to be a novel effector secreted by T3SS. Upon entry into host cell, IpgB1 
was able to induce membrane ruffles through the activation of Rac1 and CDC42 
(Kenji O, et al, 2005). IpgB1 was later shown to activate Rac1 through the RhoG-
ELMO-Dock180 pathway where IpgB1 mimics the function of Rho-GTPases by 
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binding to the N-terminal region of ELMO (Yutaka H, et al, 2007). Refer to Figure 
1.2 for the schematic representation of Shigella flexneri-mediated host cell membrane 
ruffling. 
 
Figure 1.2, Schematic view of the proposed model for Shigella flexneri-induced 
membrane ruffling. (Yutaka H, et al, 2007 and Kenji O, et al, 2005) 
 
Another effector from S. flexneri, IpgB2 was also shown to target Rho-
GTPases in host cells. Different from IpgB1, which directly mimics the function of 
Rho-GTPases, IpgB2 mimics the function of guanine nucleotide exchange factors 
(GEFs). Additionally, its structure in complex with human RhoA has been solved. 
Upon binding, IpgB2 promotes the release of guanosine diphosphate (GDP) from 
RhoA and this process is a pre-requisite for subsequent guanosine triphosphate (GTP) 
loading (Bjorn U, et al, 2010). 
Another important group of T3SS members is the chaperones. Many T3SS 
members possess extended hydrophobic regions, such as the hydrophobic 
translocators and many other apparatus subunits. Therefore they have to be associated 
with chaperones before they can interact with respective binding partners and fold 
into a mature state. The function of the chaperone is to prevent the pre-mature 
aggregation of such hydrophobic proteins and keep them in a relatively stable state 
until they meet their functional binding partner. So far, three classes of chaperones 
have been identified within the T3SSs of various gram-negative bacteria. Class I 
chaperones interact with effector proteins. These are the well-studied chaperones 
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among which, many structures have been solved, with some of them being in 
complex with their respective effectors. Although Class I chaperones share very little 
sequence homology, they all have a common fold following an α-β-β-β-α-β-β-α 
pattern (Nancy J, et al, 2010). When the known structures of chaperone-effector 
complexes were compared, a common target motif in T3SS was identified (Lilic M, 
et al, 2006, Figure 1.3). Firstly, the chaperones form a dimer as the core of the 
complex. In the case of SycN, it interacts with YscB to form a heterodimeric 
chaperone. The effectors are then “wrapped around” the chaperones in a non-native 
state. Such non-globular interaction is stabilized by two conserved β-motifs at each 
side of the chaperone dimer as well as other interacting regions that are specifically 
tailored to respective chaperone-effector complex sequences. At the two conserved β-
motif sites, the effector forms an intermolecular β-sheet with its chaperone and inserts 
several hydrophobic residues into the hydrophobic crevice on the chaperone molecule. 
This was found invariably through all the known complexes. Therefore it stands as a 
common structural motif for chaperone-effector interaction in T3SS (Lilic M, et al, 
2006). 
 
Figure 1.3, Superposition of non-globular interaction between T3SS Class I chaperones 
and the effectors. Left panel: The complex structures used were SipA-InvB (Lilic M, et al, 
2006), SptP-SicP (Stebbins and Galan, 2001), YopE-SycE (Bertalan, et al, 2002), YopN-
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SycN-YscB (Schubot F. D, et al, 2005) and YscM2-SycH (Phan J, et al, 2004). Right Panel: 
ribbon representation of the Class I chaperone SycE dimer. 
 
 Class II chaperones interact with translocators. The structures of many Class 
II chaperones have been solved. One model Class II chaperone is LcrH/SycD from 
Yersinia enterocolitica (Figure 1.4). Class II chaperones generally possess 
tetratricopeptide repeats (TPR), which are also found in Class III chaperones. TPR is 
a structural motif consisting of a degenerate 34 amino acid sequence. It is found in 
tandem arrays of 3 to 16, which form scaffolds to mediate protein–protein 
interactions and the assembly of multi-protein complexes. The binding regions of 
Class II chaperones on various translocators have been mapped by limited proteolysis. 
However, no complex structure formed by Class II chaperone and translocator has 
been reported. 
 
Figure 1.4, Ribbon representation of the structure LcrH/SycD. (Buttner, et al, 2007). 
 
Class III chaperones interact with apparatus proteins. The best-studied Class 
III chaperone complex is the needle-complex-forming subunit PscF of Pseudomonas 
aruginosa, in complex with the heteromolecular chaperones PscE and PscG (Quinaud, 
et al, 2006). The orthologue complex structure of PscEGF complex in Yersinia pestis, 
YscEGF has also been solved. Similar to the PscEGF complex, YscG is a chaperone 
with a tetratricopeptide repeat domain. It binds to the C-terminal half of YscF while 
the N-terminal 49 residues of YscF are disordered. YscE interacts with the N-terminal 
tetratricopeptide repeat motif of YscG, but it makes little contact with YscF (Sun P, et 
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al, 2007). In both complexes, the apparatus proteins, PscF and YscF, bind to the 
concave region formed by the chaperone (Figure 1.5). 
 
Figure 1.5, Ribbon and surface representation of the YscEGF complex. YscG was shown 
in grey; YscF was shown in yellow and YscE was shown in purple.  
 
1.1.5 Type VI Secretion System (T6SS) 
 The Type VI secretion system was recently identified in 2006. Since then, it 
has been discovered in many gram-negative bacteria. It was first identified as IcmF 
associated homologous protein, after the discovery that one of the genes resembled 
icmF in Type IV secretion system (Das S et al, 2003). Similar to T3SS, T6SS is also 
found to be highly responsible for pathogenesis in humans and many other animals. 
T6SS components might also constitute a phage-tail like injectisome, which can 
deliver effector enzymes or toxins into the environment or directly into the host cell 
(Cascales E, 2008; Bingle LE et al, 2008). 
 Two secreted proteins, hemolysin-coregulated protein (Hcp) and valine-
glycine repeat protein G (VgrG), are reliable indicators for the presence of T6SS. The 
crystal structure of Hcp showed a hexameric ring arrangement that polymerizes to 
form a tube with an inner diameter of 40 Å that can go up to 100 nm in length (Joseph 
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D, et al, 2006; Ballister ER et al, 2008). This suggests that Hcp may contribute to the 
conduit of T6SS through which effectors can be secreted into the environment or into 
host cell cytosol (Figure 1.6). The VgrG family of T6SS shares structural features 
with the T4 gp273-gp53 needle complex. Specifically, the N-terminal portion of VgrG 
shares similarities with gp44 protein of bacteriophage Mu. The C-terminal portion of 
VgrG shares similarities with gp5 protein of T4 phage. As gp44 is a structural 
orthologue of T4’s gp27, VgrG closely resembles the gp273-gp53 needle complex 
with a cell-puncturing structure (Pukatzki S et al, 2007). Indeed, VgrGs form multi-
meric complexes that support the hypothesis of phage-like cell-puncturing device 
formation. Some VgrG proteins carry functional C-terminal extensions, enabling 
them to function as a membrane-puncturing tip at the end of the needle complex and 
as an effector inside the host cell as well. VgrG1 of Vibrio cholerae was found to 
cross-link host cell actin which leads to the collapse of the host cell cytoskeleton 
(Sheahan KL et al, 2004). 
 
Figure 1.6, Ribbon representation of Hcp1 from Pseudomonas aruginosa. Left: ribbon 
diagram of Hcp1 monomer; Right: ribbon diagram of the hexameric ring fromed by Hcp1 
where each monomer was coloured differently 
 
 A model of Type VI secretion has been proposed based on the properties of 
Hcp and VgrG, as Hcp was found inside the periplasmic space. VgrG, after getting 
into the periplasm, forms a trimeric complex similar to the T4 bacteriophage cell-
puncturing device. Hcp may dock beneath the VgrG complex and start polymerizing 
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to form a tube. As this tube keeps growing, VgrG located at the end of the tube may 
puncture the outer membrane.  This would allow the Hcp tube to pass through, 
forming a pore on the outer membrane that allows the secretion of other effectors to 
the extracellular space (Mougous JD et al, 2007). 
 A typical T6SS usually consists of 15 to 25 genes located in a single locus. 
Most of the T6SS members were thought to be structural components of the needle 
complex with a clpB homologous ATPase that provides energy for secretion. 
However the structure of the secretion system and function of each component still 
remain poorly understood. 
 As T6SS and T3SS are the two major systems that contribute to bacterial 
pathogenesis, cross-talks have been commonly found between these two secretion 
systems, which occur mainly at the gene transcription level. Among five species 
(Salmonella enterica, Edwardsiella tarda, Aeromonas hydrophila, Vibrio cholerae 
and Pseudomonas aruginosa) whose T3SS and T6SS were the major components for 
pathogenesis, two global regulators were found connecting them and other virulence 
determinants. PhoPQ, a two-component system is widely found among Salmonella, 
Edwardsiella and Aeromonas species that are able to sense the change in temperature 
and Mg
2+
 concentration of the environment. PhoQ is a trans-membrane histidine 
sensor kinase that auto-phosphorylates itself at a conserved histidine residue upon 
activation. It transfers the phosphoryl group to the cytoplasmic response regulator 
PhoP through an aspartic acid residue. This activates PhoP, which can also function 
as a transcription regulator (Smarajit C, et al, 2010). The other global regulator found 
among Aeromonas and Vibrio species is σ54. σ54 is an alternate sigma factor required 
to initiate the ribonucleic acid (RNA) synthesis of virulence genes in many plant and 
animal pathogens. It interacts with RNA polymerase and is involved in promoter 
recognition at the site of transcription (Leung K Y, et al, 2011). 
1.2 An introduction to Edwardsiella tarda 
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 Edwardsiella tarda is a gram-negative bacillus which is facultatively 
anaerobic and motile. It was named after the renowned microbiologist P. R. Edward 
(Janda et al, 1991) and became first characterized under the enterobacteriaceae 
family in 1965 (Public Health Agency of Canada, 2001). E. tarda is a well-known 
fish pathogen with a broad range of hosts. It can live both inside and outside of its 
host, causing hemorrhagic septicemia (also known as edwardsiellosis). This is 
characterized by skin lesions and swelling which usually results in the death of the 
fish (Yousuf et al, 2006). It could also be an opportunistic pathogen to humans, 
causing gastroenteritis and diarrhea (Clarridge, 1980). Although rare, in both cases 
infection could lead to death if left untreated. E. tarda has also been shown to have a 
high affinity for red blood cells, due to its specific fimbriae that renders the ability of 
hemagglutination (Sakai et al, 2003). E. tarda is very susceptible to many common 
antibiotics like ampicillin and kanamycin. However it is quite resistant to colistin, 
streptogramin, rifampin and glycopeptides (Stock et al, 2001). Due to the rise of 
concern for antibiotic resistance (most likely because of overuse of antibiotics), it has 
become a health issue for both fish farm industry and human health.  
Studies have been focusing on the mechanism of pathogenesis for E. tarda at 
the gene and molecular level (Rao PS et al, 2004). With the characterization of T6SS 
in E. tarda (Zheng and Leung, 2007), it was again brought to the research frontier as 
the secretion systems of these pathogens could lead to a new generation of antibiotic 
development. This is because both T3SS and T6SS were present in E. tarda and 
could contribute to pathogenesis. Cross-talks between the T3SS and the T6SS in E. 
tarda have also been partially elucidated (Leung K Y, et al, 2011). The two-
component system PhoPQ acts as a global regulator whereas PhoQ senses 
environmental change such as temperature and low Mg
2+
 concentration. PhoQ 
activates PhoP by phosphorylation and PhoP, in turn, activates EsrB. EsrB is a 
regulator that is responsible for most of the T3SS genes and esrC, which encodes 
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another transcription regulator that controls T6SS genes and some specific T3SS 
genes (Figure 1.7).  
 
 
Figure 1.7, Schematic diagram representing cross communications between T3SS and 
T6SS in E. tarda. (Leung K Y, et al, 2011) 
 
Therefore, the possibility of discovering new drugs or vaccines that can 
specifically target individual secretion system components or global regulators of 
such secretion is of great interest. These drugs or vaccines will be able to repress 
bacterial virulence without affecting the viability of the bacteria by itself. Thus, only 
by “disarming” them from doing harm to their respective hosts, this will not cause the 
development of drug resistance to the antibiotic. 
1.2.1 T6SS in Edwardsiella tarda and the role of EvpP 
 The Type VI secretion system of Edwardsiella tarda was fully sequenced and 
characterized in 2007 (Zheng and Leung, 2007). There are at least 16 open reading 
frames within the gene cluster (see Figure 1.8). They were named as E. tarda virulent 
proteins (EVP) ranging from EvpA to EvpP. The transcription of EvpA to EvpO 
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might be polycistronic. EvpP lies upstream from EvpA where it might be utilizing a 
different promoter for transcription. However the transcription of other EVP members 
may also use the promoter for EvpP (Zheng and Leung, 2007). 
 
Figure 1.8, The T6SS gene cluster of Edwardsiella tarda. evp: E. tarda virulent protein; orf: 
open reading frame. (Zheng and Leung, 2007) 
Within the gene cluster, EvpP, EvpC and EvpI are the three secreted proteins 
of T6SS. EvpC is a homologue of Hcp. The crystal structure of EvpC was solved in 
2010. EvpC also forms a hexameric ring structure in high concentration like Hcp; but 
it will form a dimer in low concentration (Jobichen C et al, 2010). This suggests that 
EvpC may polymerize to form the conduit of the needle complex of T6SS. The 
secretion of EvpC and EvpI are mutually dependent while the secretion of EvpP 
requires EvpC and EvpI. Aside from the secreted proteins, most other T6SS members 
of E. tarda were thought to function as structural components. Systematic mutations 
of each of the EVP members have shown that most of the EVP members contribute to 
the virulence of E. tarda towards blue gourami fish except for EvpD and EvpJ. EvpO 
is predicted to be an ATPase protein with a walker A motif, which might be 
homologous to the ClpV (VCA116) protein from Vibrio cholerae. ClpV has been 
demonstrated to interact with VipA/VipB complex through its N-terminal domain 
where EvpA is the VipA homologue in E. tarda and EvpB is the homologue of VipB 
(Gabriele et al, 2009). Possible interactions have also been suggested between EvpO 
and EvpA, EvpL as well as EvpN (Zheng and Leung, 2007). However thus far, how 
the different components assemble into the needle complex and their respective 
function in T6SS have not yet been understood. 
One important feature about the T6SS of E. tarda is that EvpP, one of its 
secreted proteins, is unique to this species but not found (or to have homologues) 
among other gram-negative pathogenic bacteria that have been confirmed to have a 
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T6SS. EvpP has also been found in a few strains of Edwardsiella ictaluri (Yang M, et 
al, 2012). Although a strain of Aeromonas hydrophila 0865 has been reported to have 
the evpP gene; this might be due to horizontal gene transfer (Xin Wang et al, 2009). 
EvpP has been proposed as an effector protein. This is because EvpP is a secreted 
soluble protein and ∆evpP mutants of E. tarda have significantly attenuated virulence 
towards their host (Zheng and Leung, 2007; Xin Wang et al, 2009). EvpP is regulated 
by esrB and iron, through which cross-talks between T6SS and T3SS have been 
proposed (Smarajit C, et al, 2010  and Leung K Y, et al, 2011). It was also shown to 
mediate mucus adhesion, hemolysis and host serum resistance towards Japanese 
flounder (Xin Wang, et al 2009). The secretion of EvpP is dependent on EvpC and 
EvpI, where the interaction between EvpP and EvpC has been proposed. So far, the 
structure and role of EvpP for the formation of T6SS needle complex still remain 
unknown. 
1.2.2 Mapping the rigid and flexible regions of a protein 
 Proteins usually need to fold into a 3-dimensional structure (tertiary structure) 
before it can be functionally active. The information for protein folding lies within its 
primary structure, or amino acid sequence. A properly folded protein may be rigid or 
flexible to various degrees that are required for optimum function. The well-
structured part of a protein is rigid, which ensures the stability of the protein. The 
function of flexible regions of a protein is more versatile. It has been well accepted 
that flexible loop regions of enzymes have critical functional roles. Sometimes the 
change in protein structure upon binding of its partner could be dramatic. Protein 
flexibility at the level of amino acid side-chains occurs universally, and is important 
for binding and catalysis (Huber R, 1987; Kannan and Ruth, 2007; Kaare et al, 2009). 
Therefore, mapping the rigid and flexible regions of a protein could give insights on 
its global folding as well as interacting domains.  
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 Recent studies on T3SS have revealed the structural and functional versatility 
of coiled-coil domains within proteins of T3SS. Such domains consist of two or more 
α-helices forming a bundle structure. T3SS proteins with coiled-coil domains were 
often characterized by an increased structural flexibility ranging from local 
disordered regions to the formation of molten-globules. Such coiled-coil formation 
and its related structural disorder are important for their function, especially in 
establishing protein-protein interaction and self-polymerization (Anastasia D, et al, 
2009). An example would be the interaction between T3SS chaperones with their 
respective binding partners. Class I chaperones form dimers in a coiled-coil fashion 
through the central pair of α-helices (Figure 1.3). The effectors bound to Class I 
chaperones are all extensively unstructured (refer to Section 1.1.4). Translocator 
proteins of T3SS interact with Class II chaperones, which have tetratricopeptide 
repeats forming a curved layer of α-helices (Pallen et al, 2003 and Buttner et al, 2008). 
The N-terminal region of translocator protein B (outside chaperone-binding region) is 
totally disordered and the C-terminal region is thought to be responsible for 
polymerization through the interaction of coiled-coil domains. In addition, T3SS 
needle complex subunit proteins bind Class III chaperone through coiled-coil 
interactions as well. As in PscEGF complex, the C-terminal helix of PscF is stabilized 
in a helical bundle formed by part of the PscG tetratricopeptide repeats (Quinaud, et 
al, 2007). 
 Since long ago, research on protein folding and dynamics have developed a 
wide range of methods to study protein flexibility. With the current advance in 
nuclear magnetic resonance (NMR) and mass spectrometry (MS), studies on protein 
dynamics have been rejuvenated where mapping proteins’ rigid and flexible regions 
are allowed. 
1.2.2.1 Limited protease digestion 
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 One traditional way of mapping the rigid and flexible portions of a protein is 
by limited protease digestion, or limited proteolysis, using various enzymes. The 
underlining rationale is that: for the protease to be able to cleave the peptide bond of 
certain location on the substrate’s amino acid chain, the substrate has to bind and 
adapt to the specific stereochemistry of the protease’s active site (Schether and 
Berger, 1967). As the active sites of different proteases are not designed to fit the 
specific sequence of the substrate, the rigid regions of globularly folded protein are 
more resistant to such proteolysis. On the other hand, limited proteolysis often occurs 
at the sites that show a good correlation with larger crystallographic B-factor, 
uncertain electron density and larger dispersion of backbone angles (Fontana, 1993; 
1999). Therefore limited proteolysis usually takes place at sites where the substrate 
displays inherent backbone flexibility (Fontana et al, 1986; 1989). Using limited 
protease digestion followed by sodium-dodecyl-sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE), we will be able to discriminate the rigid core of a 
protein (which will remain uncleaved, thus showing up on the SDS-PAGE as a 
resultant peptide) from the flexible regions (which are susceptible to limited 
proteolysis; therefore being “chopped up” and does not show up on the SDS-PAGE). 
The identity of the band on the resultant SDS-PAGE can be further determined by 
protein sequencing or peptide mass fingerprinting. 
 Limited proteolysis has been shown to be a powerful tool to map binding 
regions between chaperones and their respective binding partners (Yih W T, et al, 
2009; Quinaud, et al, 2007). However this is not restricted to protein-protein 
complexes, as it can also help in determining the optimal boundaries for a single 
protein’s core domain. A good example would be YopR, one of the least-studied 
members of the T3SS in Yersinia. pestis, its structure being determined in 2005 
(Florian D, et al, 2005). While full length YopR failed to yield crystals; its core 
domain was elucidated (residues 38 to 149, out of a total of 165 amino acid residues) 
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after limited protease digestion by thermolysin, allowing the crystal structure to be 
determined eventually. 
1.2.2.2 Hydrogen-deuterium exchange mass spectrometry (HDX-MS) 
 Hydrogen-deuterium exchange (HDX) is a chemical process in which a 
covalently bonded hydrogen atom is replaced with a deuterium atom and vice versa. 
This often occurs on the backbone amide proton when the protein is exposed to heavy 
water (deuterium oxide, D2O) at a neutral pH level. Usually in the disordered region 
of a protein where there’s large backbone flexibility, HD exchange takes place easily 
due to the lack of protection by hydrogen bonding. Well-structured regions are more 
protected from HDX, resulting in a slow isotope exchange which is mediated by the 
amino acid’s local environment. With the advance in MS technology, MS-based 
peptide mapping is currently a widely used technique in identifying and measuring 
the mass shift of protein segments (Lars et al, 2010). Therefore, by using HDX in 
tandem with MS, we could gain structural insights into the intrinsically disordered 
regions of various proteins. 
 In HDX-MS, proteins are usually exposed to D2O for different periods of 
time, depending on the experimental design. Sample aliquots are removed and 
quenched at low pH and low temperature so as to minimize further exchange and to 
“lock in” the deuterium that is already incorporated. In order to achieve amino acid 
sequence resolution, the sample is digested by an acid-stable enzyme (usually pepsin) 
before subjected to mass spectrometry (Cravello et al, 2003). In MALDI-MS (matrix-
assisted laser desorption / ionization), samples are directly subjected to MS after 
proteolysis, while in the case of ESI-MS (electrospray ionization), one more step of 
liquid chromatography (usually HPLC, high-performance liquid chromatography) is 
recommended as it increases resolution significantly. The data collected allow us to 
analyze the change in the mass to charge ratio (m/z) of individual peptides as a 
function of time. As a result, a greater change in m/z over a designated period of time 
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indicates that these residues might be located in a less ordered region with higher 
level of solvent exposure (flexible region). Those with less HD exchange are 
supposed to be located in a well-structured region (Domon and Aebersold, 2006). 
Currently HDX-MS has become a key technique in monitoring the structure and 
dynamics of various proteins in solution (Figure 1.9). 
 Limitations of HDX-MS to probe protein intrinsically disordered regions are 
comprised of two major parts. First, HDX-MS usually has inadequate spatial 
resolution. The major advance in obtaining spatial resolution lies within proteolysis 
followed by liquid phase chromatography; however we are not able to control or 
manipulate how the enzyme digests our protein target. Although in some cases, the 
spatial resolution of HDX-MS can be enhanced up to a level of single residue by 
analyzing the HDX pattern of overlapping proteolytic fragments; it can never be 
generalized throughout the protein sequence (Der Mar, et al, 2005). In addition to 
limited spatial resolution, HDX-MS often suffers from incomplete sequence coverage 
as well, especially when applied to large and extensively glycosylated proteins. 
Proteins with multiple disulfide bonds constitute another group of targets that is 




Figure 1.9, Schematic representation of HDX-MS work flow to examine protein 
flexibility. Panel A, protein sample exposed in aqueous buffer; Panel B, protein sample 
exposed in 100% deuterium oxide; Panel C, H/D exchange occurs at the backbone amide of 
the protein followed by quenching, incorporated deuterons are “locked”; Panel D, the change 
in mass through time is monitored by mass spectrometry; Panel E, to further increase spatial 
resolution, proteins undergo proteolysis (usually by pepsin); Panel F, protein fragments are 
separated by liquid chromatography followed by mass spectrometry; Panel G, a peptide 
fragment undergoing less H/D exchange; Panel H, a peptide fragment undergoing extensive 
H/D exchange. (Robst C. E. and Kaltashov I. A. Methods Mol Biol. 2012) 
 
1.2.2.3 Protein dynamics by NMR 
 Nuclear magnetic resonance (NMR) is a widely used technique in studying 
protein structure and protein dynamics. Protein dynamics can occur at different time 
scales ranging from pico-seconds and hours, to days and even months. NMR is 
especially powerful in studying protein dynamics in the sense that the experiment 
design can be tailored to various time scales according to the mode of motion one 




Figure 1.10, Typical time scales of molecular motion and the related NMR parameters 
that describes such motion. 
 
Dynamic processes on the ~second time scale can be directly measured as a 
function of time. The NMR signal, or signal intensities are detected together with 
quantified time-correlation, the so-called “real-time” NMR (RT-NMR) (Ian R, et al, 
2011). Molecular motion processes on this time scale will include protein folding, 
solvent hydrogen exchange and relatively slow conformational changes such as cis-
trans isomerization of proline residues. The series of spectra acquired (in a time-
dependent manner) often demonstrate a progressive weakening of an initial set of 
NMR signals with or without a progressive strengthening of a new set of NMR 
signals. 
RT-NMR has been widely used in monitoring the hydrogen-deuterium 
exchange (HDX) of protein backbone amide protons. HDX-NMR utilizes the 
experiments, usually HSQC, in which 
1
H yields visible signals, but 
2
H can not. As the 
exchangeable amide protons are replaced by the solvent 
2
H (deuterium), the 
observable 
1
H signal intensity decays over time. This experiment is typically useful if 
provided with a complete set of backbone assignments correlated to the HSQC. The 
data of HDX-NMR is interpreted using the Linderstorm-Lang model (Hvidt and 




One of the experiments to study protein backbone dynamics is the 




N heteronuclear NOE. This experiment provides 
information about the motion of individual N-H bond vectors. Those that undergo 
motion faster than the overall tumbling of the molecules, in other words, has a higher 
level of backbone flexibility, will show a decreased NOE intensity relative to the 
average observed for the majority of the residues. Therefore as an example, decreased 
NOE intensities are usually observed at both N- and C-terminal ends of a protein 
where they do not form steady structures. In addition, spin-lattice relaxation (T1), 
spin-spin relaxation (T2) and spin-lattice relaxation in the rotating frame (T1ρ) also 
provide important information on the time scale of motion for individual residues that 








N-edited T2 (usually replaced by 
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heteronuclear NOE data are usually determined by modified 2D HSQC-like NMR 
experiments on 
15
N-edited proteins. In general, shorter relaxation time implies a faster 
motion of individual residues. 
Another important parameter that can also reflect protein motion is the 
linewidth of the observable NMR signal. Under normal circumstances, the linewidth 
is defined to be the NMR signal at its half-height (W1/2) and can be related to T2 by 
the equation W1/2=1/(πT2). Linewidth can be a general indicator for the overall 
tumbling time of a protein molecule. It is also highly related to the protein’s 
molecular weight. Typically, the larger the molecule is, the broader the linewidth is 
expected to be. A larger-than-expected linewidth value may indicate a multimeric 
formation of such molecules (sometimes aggregation) or protein unfolding. 
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Protein side-chain dynamics occur at time scales ranging from milliseconds 
to picoseconds which are often related to the thermodynamics of folding, molecular 
interaction or conformational entropy. Side chain methyl C-H bond vectors, N-H 
bond vectors in the carboxyamide groups of asparagine and glutamine, as well as the 
secondary amines of arginine and tryptophan are generally used to probe side-chain 
dynamics (Nikola T, et al, 2009). Most side chain dynamics on time scales of 
milliseconds to microseconds can be studied using 
13
C relaxation dispersion. Protein 
internal side chain motions on even faster time scales (ranging from nanoseconds to 
picoseconds) can be measured using auto- and cross-related relaxation as well as 
cross-relaxation (Yang D, 2011). 
1.3 An introduction to Aeromonas hydrophila 
 Aeromonas hydrophila is a gram-negative bacterium that is oxidase-positive, 
anaerobic, and rod-like in shape with polar flagella. It can be found in most aquatic 
environments around the world (Albert M et al, 2000). A. hydrophila is one of the 
major pathogens to fish, causing motile aeromonas septicemia. It is also pathogenic to 
humans as well. Clinic symptoms associated with aeromonas infection includes 
gastroenteritis, wound infection and other systematic diseases (Austin B et al, 1996). 
Aeromonas hydrophila is resistant to many common antibiotics like penicillin and 
ampicillin. It is also able to grow at low temperatures while thriving at higher 
temperatures between 25°C to 37°C. Although antibiotics like tetracycline, 
chloramphenicol and florenicol have been used to control aeromonas infections, 
concerns about drug resistance have always remained an issue. 
1.3.1 Translocator operon of Aeromonas hydrophila 
 Similar to other gram-negative bacteria, the presence of a functional T3SS is 
essential for the pathogenesis of Aeromonas. hydrophila. Two kinds of proteins are 
secreted by the T3SS injectisome, effectors and translocators. Effector proteins are 
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usually delivered directly into the host cell cytosol where they will carry out specific 
functions such as rearrangement of host cell cytoskeleton, apoptosis of host cell, 
repressing host cell immune system that promote bacteria entry and survival (Zaharik 
ML, et al, 2002). In order for the effectors to be directly injected into the host cell, 
three proteins are needed to serve this purpose, two of which are hydrophobic 
translocators and the third is hydrophilic. A well-studied model system is the 
translocator operon of the Yersinia species (see Figure 1.11). Within the translocator 
operon, YopB and YopD are the two hydrophobic translocators while LcrV is the 
hydrophilic one. YopB and YopD were found to be inserted into host cell membrane, 
forming a pore that allows the transport of effector proteins directly into host cell 
cytosol (Neyt and Cornelis, 1999; Goure et al, 2005). The insertion of hydrophobic 
translocators into the host cell membrane is dependent on the hydrophilic translocator 
LcrV; although LcrV itself is not inserted. In the same operon, sycD/lcrH encodes a 
Class II chaperone for both YopB and YopD. Similar translocator operons were also 
found in Pseudomonas species. 
 
Figure 1.11, The translocator operon in different species. Translocators are coloured red; 
Class II chaperones are coloured green; hydrophilic protein is coloured blue. (Mueller C. A. et 




 A. hydrophila has a T3SS with a translocator operon similar to the one in 
Yersinia. AopB and AopD are two hydrophobic translocators that are homologous to 
YopB and YopD. Inactivation of these two translocators results in decreased 
cytotoxicity in carp epithelial cells, increased phagocytosis and reduced virulence 
towards blue gourami fish (Yu HB et al, 2004). In the same operon, the gene acrH 
encodes the Class II chaperone AcrH which has been found to be able to form protein 
complexes with both AopB and AopD (Yih Wan Tan, et al, 2009). The crystal 
structure of the chaperone protein LcrH/SycD in Yersinia has been solved. LcrH is a 
pure α-helical protein with tetratricopeptide repeats (Carina B, et al, 2007). It 
interacts with YopB and YopD using two distinct regions. YopB binds to the concave 
binding groove while YopD binds to the outer convex (Edqvist PJ et al, 2006). AcrH 
was found to form complexes with either AopB or AopD in a one to one ratio, while 
the three of them can form a larger complex that is metastable (Yih Wan Tan, et al, 
2009). The AcrH-binding regions of AopB and AopD have also been mapped 
respectively by limited protease digestion. AopD binds AcrH using two discrete 
regions: DF1, from Val16 to Leu147 and DF2 from Ser242 to Phe296 (digested by 
chymotrypsin). AopB binds AcrH through one continuous region, from Ala33 to 
Leu264 (digested by elastase) (Figure 1.12). The C-terminal part of AopB, a putative 
coiled-coil domain, is not involved in binding with its chaperone. However it is 
proposed to be responsible for protein complex oligomerization (Yih Wan Tan, et al, 
2009). Although the structure of Class II chaperone has been solved and we have 
some insight into its interaction stoichiometry with the translocators; no complex 
structure formed between Class II chaperone and the translocator has been reported 




Figure 1.12, Sequence alignment of AopB from Aeromonas hydrophila with YopB from 
Yersinia enterocolitica and PopB from Pseudomonas aeruginosa. The AcrH-binding region 
of AcrH was boxed. Predicted trans-membrane domains were highlighted in grey. Coilded 
coil regions were marked in bold. 
 
1.4 General objective and significance of this study 
 Type VI secretion system (T6SS) is a recently discovered secretion system 
which plays an important role in the pathogenesis of various gram-negative bacteria. 
Edwardsiella tarda, being one of the major fish pathogens, was also found to possess 
a functional T6SS. Within the gene cluster of T6SS in E. tarda, EvpC has been 
demonstrated to be an Hcp homologue and its structure was determined to be similar 
to Hcp1 (Jobichen C et al, 2010). Other than this, little is known about the structure or 
topology of the needle complex. EvpO is proposed to be an ATPase that provides 
energy to drive Type 6 secretion. EvpA and EvpB share homology with VipA and 
VipB, which are found in Vibrio cholerae. It has been reported that ClpV, a potential 
ATPase protein in Vibrio cholerae, interacts with VipA and VipB through its N-
terminal domain while VipA/VipB has been shown to form tubule-like structures 
(Gabriele et al, 2009). Yet, no direct evidence of such EvpA and EvpB interaction has 
been reported.  
More importantly, T6SS gene cluster of E. tarda harbours one unique gene, 
evpP, which is not found in any other gram-negative bacteria that possess a T6SS. 
EvpP is a novel secreted protein by the T6SS that contributes to the virulence of E. 
tarda. Recent studies at the genetic level have gained some insights to the functional 
potentials of EvpP (Xin Wang et al, 2009). Relatively little is understood about EvpP 
at the protein level: the structure as well as the interacting partners of EvpP still 
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remain unknown. Therefore our primary research objective was to characterize the 
properties of EvpP protein. We attempted to investigate the structure of EvpP in 
terms of mapping its rigid and flexible regions by obtaining its NMR backbone 
chemical shift assignment, amide proton exchange mass spectrometry as well as 
limited protease digestion. In addition, we attempted to examine its potential 
interacting partners within the T6SS gene cluster, as EvpP has been reported to be 
able to interact with EvpC (Zheng and Leung, 2007). 
One fascinating feature about T3SS and T6SS is their ability to directly inject 
effectors from bacterial cytoplasm into host cell cytosol where various effectors can 
interact with host cell entities. Within T3SS of Aeromonas hydrophila, the pore-
forming translocators AopB and AopD were found to be inserted into the host cell 
membrane where they polymerize to form a pore that is continuous from the 
injectisome of T3SS, allowing the direct transportation of effectors. As AopB and 
AopD are highly hydrophobic proteins, they have to be kept stable (perhaps in their 
nascent form) by the Class II chaperone AcrH before folding into mature form to 
become functionally active. AcrH shares a high homology with LcrH/SycD from 
Yersinia species in terms of secondary and tertiary structure. Similar to SycD, AcrH 
is also believed to be an α-helical protein with tetratricopeptide repeats (Pallen et al, 
2003). Although AcrH has been shown to interact with either AopB or AopD in a one 
to one ratio, and the AcrH-binding regions on AopB and AopD have been mapped 
(Yih Wan Tan, et al, 2009), no structure of Class II chaperone in complex with a 
translocator has been reported yet. Therefore our primary research objective is to 
optimize the boundaries of the translocator-chaperone complex of AcrH-AopB by 
further limited protease digestion. The foundation of this research was based on the 
results of previous studies (Y W Tan, H B Yu, J Sivaraman, K Y Leung and Y K 
Mok, Protein Science, 2009). We also attempted to crystalize the complex of AcrH-




CHAPTER 2, MATERIALS & METHODS 
2.1 Subcloning of EvpP and its mutants into expression vector 
2.1.1 Bacterial host strains 
Strain Genotye 
DH5-α F- Φ80dlacZΔM15 &(lacZYA-argF) U169 recA1 endA1 hsdR17(rk
-
,mk
+) phoA supE44 λ- thi-1 gyrA96 relA1 
BL21-DE3 F- ompT hsdSB(rB
-mB
-) gal dcm 
Table 2.1, Strains used for protein subcloning and expression 
2.1.2 Generation of DNA insert and Polymerase Chain Reaction 
 DNA insert of EvpP as well as its truncation mutants (see table 2.2 for the 
primer sequences used) were generated by polymerase chain reaction (PCR), using 
upstream oligonucleotide primer with a BamH I restriction site and downstream 
oligonucleotide primer with a stop codon and an EcoR I restriction site. PCR reaction 
mix was prepared in 50 μl mix containing 1 X Pfu buffer (20 mM Tris-HCl, pH 7.5 at 
25°C, 8 mM MgCl2, 0.5 mM DTT, 50 mg/ml BSA), 1 μl of E. tarda strain 130/91 
genomic DNA template, 0.4 μM of each primers, 200 μM of each dATP, dCTP, 
dGTP and dCTP, and 1 μl of 1 U KOD Hot Start Pfu DNA Polymerase (Novagen). 
 PCR was carried out for 30 to 35 cycles, following the subsequent protocol: 
95°C of denaturation for 30 sec, 55°C of primer annealing for 30 sec (usually this 
temperature is adjustable according to the melting temperature of the primer), 72°C of 
extention for 30 sec (this is also adjustable according to the length of the PCR 
product). The PCR product was mixed with 1X DNA loading dye and analysed on 1% 
agarose gel electrophoresis. The desired band was recovered by Gel Extraction Kit 
(QIAGEN) following the standard manufacturer’s protocol. 
Table 2.2, Table of PCR Primers for EvpP and its Truncation Mutants. FP: 
forward primer; RP: reverse primer 
EvpP21-endFP 




5' CGG AAT TCT TAT TTC AAG GCT GAA AAG 3'   
EvpP76-endFP 
5' CGG GAT CCT TCC GCC ACG ATG GC 3'   
EvpPFP 
5' CGG GAT CCA TGT CGA TTT TGA ATT C 3'   
EvpP1-74RP 
5' CCC AAG CTT CTG GAC CGG GCT CCA C 3'   
EvpP1-86RP 
5' CCC AAG CTT CAT ACG CTG CTG CAG 3'   
EvpP1-88RP 
5' CCC AAG CTT GAC CAG CAT ACG CTG 3'   
EvpP1-92RP 
5' CCC AAG CTT GTT TAG CTT AGC GAC 3'   
EvpP1-123RP 
5' CCC AAG CTT TCA AAC CTT TAG GAC TAT C 3'   
EvpP1-142RP 
5' CCC AAG CTT TCA CAT ACC ATT ATC AAT AC 3'   
EvpP1-159RP 
5' CCC AAG CTT TCA GAG GTT CGA TCC CC 3'   
EvpP1-168RP 
5' CCC AAG CTT TCA AAT ATA GAA CTG TGT G 3'   
 
 
2.1.3 Generation of mutant DNA insert for site directed mutagenesis 
 Mutant DNA inserts of EvpP were generated by employing the modified 
QuikChange
TM
 Site-Directed Mutagenesis Kit (Stratagene) designed oligonucleotide 
primers (1
st
 Base) with mismatches. Primers were designed with mismatches base 
pairing being flanked on both 5’ and 3’ ends with about 9 to 15 bases each using the 
software GeneRunner. The list of mismatched primers for EvpP could be seen in 
Table 2.3. The PCR using the high fidelity KOD Hot Start Pfu DNA Polymerase 
(Novagen) generated the whole plasmid consisting of the desired mismatched bases. 
The methylated wild-type plasmids were digested by adding 1 μl of 1 U Dpn 1 Fast 
Digest
TM
 restriction enzyme at 37°C for 1 hour. The mixture was subsequently 
purified using the spin columns (QIAGEN) followed by direct transformation into 
BL21 (DE3) competent cells. The list of primers used is shown in Table 2.2. PCR 
amplification was carried out with similar procedure as described in section 2.1.2 
except that the elongation time was adjusted to 5 min. A flow chart of this method 




Figure 2.1, Generation of site-directed mutants. The high fidelity Hot Start KOD DNA 
Polymerase enabled the amplification of the DNA insert together with the vector. Dpn 1 
restriction enzyme was used to digest the methylated wild-type parental DNA template. 
Finally, the nicked dsDNA was repaired in the BL21 (DE3) competent cells. 
EvpP P20A FP 
5' GT ATT TCT ACA GGC GCA GGC ACC GTC GTC AG 3'   
EvpP P20A RP 
5' CT GAC GAC GGT GCC TGC GCC TGT AGA AAT AC 3'   
 
EvpP P58S FP 
5' GTT CAT TGG CAA GGT CCC CGA TCA CTG ACG ATA C 3'   
EvpP P58S RP 
5' GTA TCG TCA GTG ATC GGG GAC CTT GCC AAT GAA C 3'   
 
EvpP L91Q FP 
5' GCT GGT CGC TAA GCA AAA CGG CGT ATC AAT G 3'   
EvpP L91Q RP 
5' CAT TGA TAC GCC GTT TTG CTT AGC GAC CAG C 3'   
 
EvpP P143T FP 
5' GTA TTG ATA ATG GTA TGA CCT CTA AAC GAA ATA TC 3'   
EvpP P143T RP 
5' GAT ATT TCG TTT AGA GGT CAT ACC ATT ATC AAT AC 3'   
 
EvpP G156S FP 
5' GAA CAA AAA GGC AGG TCA TCG AAC CTC CCC GGC 3'   
EvpP G156S RP 
5' GCC GGG GAG GTT CGA TGA CCT GCC TTT TTG TTC 3'   
Table 2.3, List of primers used to generate mutant DNA inserts of EvpP. FP: forward 
primer; RP: reverse primer. 
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2.1.4 Preparation of competent cells 
 Frozen glycerol stock of DH5α or BL21 (DE3) was streaked onto plain LB 
agar plate and incubated overnight at 37°C. A single colony was inoculated into 8 ml 
of LB broth and incubated in a shaker overnight at 37°C. 1 ml of overnight culture 
was transferred into 100 ml of LB broth and incubated in a shaker at 37°C with 
shaking speed of 200 rpm. Cells were grown until O.D600 reached 0.4 and then 
transferred into 50 ml tubes and spun at 3,500 rpm for 10 minutes at 4°C. Supernatant 
was removed and cell pellets were resuspended gently with 40 ml of cold glycerol 
buffer (0.1 M CaCl2, 15% glycerol) and then incubated on ice for 30 minutes. Cells 
were spun at 3,500 rpm for another 10 minutes at 4°C and the supernatant was 
removed. The pellet was resuspended carefully in 4 ml of cold glycerol buffer and 
incubated on ice for 2 hours before aliquoted at 50 μl per tube. The aliquots were 
quickly freezed in liquid nitrogen before transferring to storage at -80°C. 
2.1.5 Subcloning 
 For His-tagged proteins, DNA inserts of EvpP and its truncation mutants 
(Table 2.1) were subcloned into pET-M, a modified vector from pET-32a with S-tag 
and thioredoxin tag removed. For GST-tagged proteins, the inserts were subcloned 
into pGEX-4T-1 vector (Novagen). The DNA insert (about 50 ng/μl) was digested 
using 10 U of BamH I Fast Digest 
TM
 and EcoR 1 Fast Digest 
TM 
(both from 
Fermentes) in a total reaction volume of 40 μl. Two microliter of expression vector 
(about 50 ng/μl) was digested in a separate tube with another 10 U of the similar 
restriction enzyme in total reaction volume of 20 μl. Concentrated 10 X Fast Digest 
TM 
buffer was added accordingly. Both tubes were incubated in 37°C water bath for at 
least 1 hour. 
 The plasmid and DNA insert digestion products were mixed together and the 
mixture was purified using the spin column (QIAGEN) with a final elution volume of 
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35 ul. The ligation of DNA insert and plasmid was done by adding 4 μl of 10 X T4 
ligase buffer and 1 μl of T4 ligase enzyme (Fermentes). Ligation was carried out for 
at least 1.5 hour at room temperature before transformation into DH5-α competent 
cell. 
2.1.6 Transformation of ligation mix into DH5-α competent cell 
 Ligation reaction was added into a tube containing 50 μl of DH5-α competent 
cell and kept on ice for 30 minutes. Heat shock was carried out by incubating the cells 
at 42 °C for exactly 90 seconds, followed by 2 minutes incubation on ice. 900 μl of 
LB broth was added into the tube before the recovery incubation at 37 °C with 
shaking for one hour. Cells were centrifuged at 6,000 rpm for 2 minutes and 900 μl of 
the supernatant were removed. Cell pellet was resuspended with the remaining 
medium and plated on LB agar plates supplemented with 0.1 mg/ml ampicillin. Plates 
were incubated overnight in a 37 °C incubator. 
2.1.7 PCR screening of transformant 
 The presence of DNA insert inside target plasmid was verified by PCR 
screening of colonies grown on LB-ampicillin agar plate prior to DNA sequencing. 
At least six colonies from each plate were selected for screening. Half of a colony 
was picked using a sterile pipette tip and inoculated into 100 μl of sterile water in an 
eppendorf tube. The suspension was boiled (or heated on a heat block) for five 
minutes and subsequently centrifuged at 13,000 rpm for a minute. One microliter of 
the supernatant could be used as the DNA template for PCR reaction. 
 The PCR reaction cocktail of 10 μl was prepared containing 1 X Taq reaction 
buffer (50 mM KCl, 10 mM Tris-Cl pH 9.0, 1% Triton X-100), 0.75 mM MgCl2, 140 
μM of each dATP, dCTP, dGTP and dCTP, 0.5 μM each of forward and reverse 
primer; and 1.5 U of Taq DNA Polymerase (Promega). One microliter of DNA 
template was added into the mixture and 30 to 35 PCR cycles were carried out with 1 
33 
 
minute denaturation at 94 °C, 1 minute annealing at 52 °C and 1 minute elongation at 
72 °C for each cycle. The PCR products were analyzed on a 1% agarose gel for the 
detection of DNA fragment of appropriate size. 
2.1.8 Isolation of DNA plasmid 
 Colonies that showed positive PCR screening results were inoculated into LB 
broth (containing 100 μg/ml ampicillin) and cultured overnight at 37 °C with shaking. 
Cell pellets from 5 ml of overnight culture were recovered by centrifugation at 6,000 
rpm for 15 minutes. DNA plasmid was extracted from pelleted cells using QIAGEN 
Miniprep Kit (QIAGEN) and eluted with 30 μl of elution buffer (QIAGEN) or water 
according to the supplied protocol. 
2.1.9 DNA sequencing 
 Two microliter of plasmid DNA (about 250 ng of DNA) was added into a 
reaction mix containing 3 μl of water, 1 μl of T7-promoter sequencing primer (3.2 
μM), 2 μl of 5X Big Dye Buffer and 2 μl of Big Dye Terminator V3.1 (Applied 
Biosystems). Thirty cycles of sequencing PCR reaction were carried out with 
denaturation step at 96 °C for 30 seconds, annealing at 50 °C for 25 seconds and 
extension at 60 °C for 4 minutes. Following the sequencing cycle, a mixture of 3 μl of 
3M sodium acetate, pH 4.6, 62.5 μl of 95 % ethanol and 24.5 μl of sterile water was 
added into each DNA sample for precipitation. After 1 hour (or at least 15 minutes) 
incubation at room temperature, the mixture was centrifuged at 13,000 rpm for 20 
minutes at room temperature. Supernatant was removed, and the pellet was washed 
twice with 500 μl of 70% ethanol and centrifuged for another 5 minutes during each 
wash. Supernatant was carefully removed and the DNA pellet was dried in a vacuum 
centrifuge (Speed-Vec) before sequencing analysis on an automated sequencer, ABI 
PRISM 3100 (Applied Biosystems). 
2.2 EvpP protein expression and purification 
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2.2.1 Transformation of plasmid into BL21 (DE3) competent cell 
 Plasmid containing DNA insert or mutants was transformed into E. coli BL21 
(DE3) cells for the expression of recombinant protein. Transformation procedure was 
carried out in the same way as described in section 2.1.6. 
2.2.2 Protein expression 
 A single colony of E. coli BL21 cells containing the desired plasmid was 
inoculated into 10 ml of LB broth (containing 100 μg/ml ampicillin) and cultured at 
37°C overnight with shaking. Ten milliliter of overnight culture was inoculated into 1 
liter of autoclaved LB broth (containing 0.1 mg/ml ampicillin). Cultures were grown 
at 37°C with shaking at a speed of 200 rpm for approximately 3 hours or until the 
O.D600 reached approximately 0.6. Subsequently, IPTG was added at a final 
concentration of 0.4 mM to induce protein expression. The culture was further grown 
at 20°C to 25°C overnight at 200 rpm. Cells were harvested by centrifugation at 6,000 
rpm for 15 minutes at 4 °C. Cell pellets were kept at -20 °C until purification. 




C-labeled protein was carried out with similar 
conditions as mentioned above, except that the cells were grown in M9 minimal 
medium (Appendix I) supplemented with 
15
N-labeled ammonium chloride and/or 
13
C-





labeled sample), cells were grown in 1 X M9 minimal medium in the presence of 
15
N-
ammonium chloride (Cambridge Isotope Laboratories) or with 
13
C-glucose 










C-glucose (Cambridge Isotope Laboratories) was used as the sole nitrogen and 
carbon source respectively. 
2.2.3 Protein purification using nickel-affinity chromatography 
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 Cells from one liter culture were resuspended in 30 ml of nickel binding 
buffer (20 mM Tris-Cl pH 8, 0.5 M NaCl, 5 mM imidazole). The suspension was 
sonicated for 3 minute each time at 38% sonication amplitude for 4 to 5 times. The 
lysate was centrifuged at 4°C for 30 minutes at 18,000 rpm. The supernatant was 
collected for purification. Around 10 ml of Ni-NTA beads (QIAGEN) were charged 
with 20 ml of Nickel-charge buffer (50 mM NiSO4), washed with 3 colume volume 
of water and equilibrated with 1 X Nickel binding buffer in a chromatography column. 
All supernatant was slowly loaded into the column, mixed well and let flow at 
approximately 1 ml/min. The column was subsequently washed 15 times (or at least 
10 times) with 1 X nickel washing (20 mM Tris-Cl pH 8, 0.5 M NaCl, 20 mM 
imidazole) buffer to remove any unbound or loosely bound proteins. His-tagged 
protein was eluted out using 30 ml of nickel elution buffer (20 mM Tris-Cl pH 8, 0.5 
M NaCl and 500 mM imidazole). The eluted protein was dialyzed overnight against 
20 mM Tris-Cl pH 7 and analyzed by SDS-PAGE. 
2.2.4 Protein refolding by rapid dilution 
 As all the EvpP truncation mutants were insoluble and expressed in inclusion 
bodies; they were subjected to protein refolding in order to explore the possibility to 
get any soluble form of EvpP truncation mutants. His-tagged EvpP truncation 
mutants (Table 2.3) were purified in the same way as described in section 2.2.3 
except that all the buffers used contain additional 8 M Urea (or 6 M guanidine 
hydrochloride, refer to Appendix II for buffer recipe). For refolding, 100 µl of eluted 
protein (denatured in 8 M Urea) was added into 3 ml refolding buffer (usually Tris 
pH7 or pH8, phosphate buffer pH6, MES buffer pH5 or Acetate buffer pH4) drop by 
drop with rapid stirring on a electric magnetic stirrer. The same procedure was carried 
out repeatedly for 100 times or until sufficient amount of denatured protein being 
refolded. The protein solution (in refolding buffer) was pooled together and 
concentrated to around 50 ml in volume and subjected to dialysis for further removal 
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of residual Urea or Guanidine Hydrochloride. The dialyzed protein solution was 
centrifuged at 6,000 rpm for 20 min and the supernatant was collected and analyzed 
on SDS-PAGE or CD. 
2.2.5 Protein purification using GST affinity chromatography 
 Cells expressing EvpP (wild type as well as its truncation or site-directed 
mutants) from 1 liter culture were resuspended in 30 ml of PBS (140 mM NaCl, 2.7 
mM KCl, 10 mM Na2HPO4 and 1.8 mM KH2PO4, pH7.4). The suspension was 
sonicated for 3 minute each time at 38% sonication amplitude for 4 to 5 times. The 
sonication lysate was centrifuged for 30 minutes at 18,000 rpm and 4°C. The 
supernatant was collected for purification. All supernatant was slowly loaded into a 
column packed with 10 ml of glutathione-sepharose 4B beads (Amersham 
Biosciences) equilibrated with 1 X PBS. The column was subsequently washed 15 
times with a total of 1 X PBS to remove any unbound or loosely bound proteins. 
GST-tagged protein was eluted with 30 ml of glutathione elution buffer (50 mM Tris-
Cl pH 8 and 10 mM reduced glutathione) and analyzed by SDS-PAGE. Glutathione-
sepharose beads were regenerated by washing the column twice with column 
regeneration buffer 1 & 2 (Appendix II). 
2.2.6 Gel filtration FPLC (Fast Performance Liquid Chromatography) 
 Gel filtration, FPLC was carried out through a HiLoad 16/60 Superdex 75 (or 
Superdex 200, in case of purification of AcrH-AopB complex) pg size exclusion 
chromatography column on AKTA FPLC System (Amersham Biosciences) using 20 
mM Tris-Cl pH7 with 200 mM NaCl as running buffer. Gel filtration column was 
pre-equilibrated with at least three column volumes (180 ml) of running buffer before 
usage. Protein sample was concentrated to around 5 ml prior to loading. 
Chromatography was carried out at a flow rate of 1 ml/min for a total volume of 180 
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ml. Eluted protein peaks were detected by measuring UV absorbance at 280 nm and 
the respective fractions were analyzed by SDS-PAGE. 
2.2.7 Ion exchange chromatography 
 For the purification of trypsin digested EvpP (wild type), ion exchange 
chromatography was carried out through a Mono Q
TM
 10/100 GL (Amersham 
Biosciences) column on AKTA system (Amersham Biosciences) using 20 mM Tris-
Cl pH9 as buffer A and 20 mM Tris-Cl pH9, 1 M NaCl as buffer B. The column was 
pre-equilibrated with at least 3 column volumes of buffer B followed by 6 column 
volumes of buffer A before loading of protein samples. Protein samples were 
concentrated to around 2 ml prior to loading. Chromatography was carried out at a 
flow rate of 4 ml/min until target concentration of buffer B was reached (usually 100% 
of buffer B was used as final concentration). Eluted protein peaks were detected by 
measuring UV absorbance at 280 nm and the respective fractions were analyzed by 
SDS-PAGE. 
2.2.8 Sodium-dodecyl-sulphate polyacrylamide gel electrophoresis (SDS-
PAGE) 
 SDS-PAGE was carried out according to the method described by Laemmli 
(1970). Polyacrylamide gel was cast according to the table described in Appendix III 
using the Mini-PROTEAN 3 system (Bio-Rad). Protein sample was mixed with an 
equal volume of 2 X SDS sample buffer and boiled for 5 minutes before loading into 
the wells of the polyacrylamide gel. Fifteen microliter of sample was loaded into each 
well, and electrophoresis was carried out at 200 V for 50 min or until the dye front 
reached the end of the gel. The gel was stained with Coomassie blue staining solution 
for about 20 minutes and then destained in destaining solution (Appendix III) 
overnight. 
2.3 Dynamic light scattering (DLS) 
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 Dynamic light scattering was carried out for both EvpP and its mutant 
EvpP_P143T using DynaPro Dynamic Light Scattering (ProteinSolutions) machine 
linked to a Temperature Controlled MicroSampler (ProteinSolutions). Twenty 
microliter of protein sample was loaded into a quartz cuvette with a path length of 15 
mm (ProteinSolutions). Data were recorded and analyzed using the Instrument 
Control Software for Molecular Research (ProteinSolutions). 
2.4 Limited protease digestion of EvpP 
 Limited protease digestion (enzymes used were trypsin, thrombin, 
chymotrypsin, elastase, thermolysin and papain) was carried out for both EvpP and its 
mutant EvpP_P143T using protein samples in its native buffer (20 mM Tris-Cl pH7) 
with different enzymes at different ratio (usually 1:50, 1:100 or 1:200). Both the 
protein sample and the enzyme stock were prepared to be 1 mg/ml in concentration. 
Ten microliter of enzyme solution was added into 1 ml of protein sample to form the 
reaction mixture. Aliquots were removed from the reaction mixture every 10 min and 
mixed with equal volume of 2 X SDS sample buffer and boiled at 100°C for 5 min. 
All the aliquots were analyzed on SDS-PAGE subsequently. 
2.5 Protein cross-linking assay by glutaraldehyde 
 For glutaraldehyde treatment of wild type EvpP, the buffer need to be 
changed to 20 mM phosphate buffer pH7.0. One hundred microliter of protein sample 
(at a concentration of 1 mg/ml) was treated by 5 µl of freshly prepared 2.3% solution 
of glutaraldehyde for 10 min at 37°C. The reaction was terminated by the addition of 
10 µl Tris-Cl pH8.0. Treated protein samples were mixed with equal volume of 2 X 
SDS sample buffer and boiled for 5 min before they were analyzed on SDS-PAGE. 
2.6 Mass spectrometry 
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Trypsin digested EvpP samples were blotted onto a MALDI target plate with 
sinapinic acid as a matrix. The molecular weight of each component in the complex 
was determined using Voyager-DE STR Mass Spectrometer (GE Healthcare). A 
voltage of 2100V and laser intensity of 2500 was used for the experiment. 
2.7 Protein sequencing (N-terminal amino acid analysis) 
For N-terminal sequencing studies, EvpP proteins (after limited proteolysis 
by various enzymes, refer to Section 2.4 for the enzymes used) need to be 
immobilized onto a membrane by western blot before sequencing. Protein samples 
were separated on a 15% SDS-PAGE or 15% Tricine-SDS-PAGE. The proteins 
separated on the gel were blotted onto a PVDF membrane (Milipore) using a Mini 
Trans-blot Electrophoretic Tranfer Cell (Bio-Rad). Trans-blotting was performed at 
4C at a voltage of 90V for 90 min or until complete transfer of protein bands onto 
the PVDF membrane. Protein bands on the membrane were visualized by coomassie 
blue staining and excess stain on the membrane was removed by washing with a 50% 
methanol solution. Membrane-bound protein bands were excised and N-terminal 
residues were fragmented using Procise Protein sequencing system (Applied 
Biosystems). Data were collected and analyzed using SequencePro Data Analysis 
Application software v2.1. 
2.8 Circular dichroism (CD) spectroscopy 
 Circular dichroism experiments were carried out with 20 μM EvpP protein 
(or more) in 20 mM Tris-Cl pH7.0 buffer. The spectra were acquired with a J-810 
Spectropolarimeter (Jasco, Japan) using a quartz cuvette with 1 mm pathlength 
(Hellma, Germany). The spectra were recorded at wavelength region from 190 nm to 
260 nm at 0.1 nm resolutions with a scan speed of 50 nm/min and a response time of 
8 seconds, averaged over 10 scans. 
2.9 Urea denaturation experiments by fluorescence spectroscopy 
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 Urea denaturation experiments were carried out by mixing samples of EvpP 
and its mutants (P20A, P58S, L91Q, P143T, G156S) at an initial concentration of 100 
µM, and denaturing buffer (20 mM Tris-Cl with 10 M Urea) at different ratios to 
achieve Urea concentration from 0 M to 8 M with an increment of 0.5 M each. The 
resultant protein concentration was 20 µM. 
 Protein samples were loaded into a fluorescence cuvette with a path length of 
10 mm (Perkin Elmer Instruments) and the fluorescence spectra were recorded using 
an LS55 Luminescence Spectrometer (Perkin Elmer Instruments). Data were 
analyzed using FL WINLAB software. Curve fitting was performed using 
Kaleidagraph ver4.0. 
2.10 Sequence alignment 
 Amino acid sequence alignment of EvpP (130/91) against other species was 
carried out using ClustalW (Higgins et al, 1994) software hosted at European 
Bioinformatics Institute server (EBI,http://www.ebi.ac.uk/Tools/). Amino acid 
sequences were acquired from GenBank (http://www.ncbi.nlm.nih.gov/). 
2.11 Nuclear magnetic resonance and backbone assignment 
 3D and 4D heteronuclear NMR experiments were carried out to assign the 





HSQC as a reference spectrum. All NMR experiments were carried out on a Bruker 
AVANCE 800 MHz spectrometer equipped with a cryoprobe. Samples were loaded 
into a 5 mm NMR tube and all experiments were carried out at 297K. All data 
acquired were processed using NMRPipe (Delaglio, Grzesiek et al. 1995) and 
analyzed using NMRDraw (Delaglio, Grzesiek et al. 1995), SPARKY (Goddard and 
Kneller) and NMRSpy (Zheng, Yu; Yang, Daiwen. NMRspy, National University of 
Singapore). Computational processing was carried out on Dell Precision 360 












N HSQC spectrum was used as a reference for backbone chemical 
shifts assignments by other 3D or 4D experiments. The spectrum was acquired with 
1280 complex points over a spectral width of 11160.714 Hz on 
1
H dimension. In the 
15




N were at 4.782 ppm and 119.079 ppm respectively. 
2.11.2 HNCACB and CBCA(CO)NH of deuterated EvpP 
 As His-tagged EvpP is 22 kDa and it was thought to have a dimeric form in 
solution; normal HNCACB and CBCA(CO)NH could not get a good signal-to-noise 
ratio. The experiment had to be done using deuterated EvpP protein sample. 
Complete deuteration of EvpP was achieved by culturing EvpP-expressing E. coli 
cells in M9 minimal medium that was completely prepared using deuterium oxide 
(D2O) instead of hydrogen oxide (H2O). The deuterated proteins were then purified 
by the standard Ni-NTA affinity chromatography using all aqueous buffers so that the 
backbone amide protons (but not the others) could be exchanged back to hydrogen. 
 Backbone assignments were carried out by HNCACB and CBCA(CO)NH 
experiments. The CBCA(CO)NH experiment correlates both the Cα and Cβ chemical 
shift with the amide from the previous residue while HNCACB provides the intra-
residue correlation of its own Cα and Cβ while often, the Cα and Cβ from the 
preceding residue could also been seen. These two experiments provided chemical 
shift information for sequential assignments. 
 For HNCACB experiment, in the acquired dimension 
1
H, 1280 points were 
collected over 11160.714 Hz of spectral width. In the dimension 
15
N, 100 points were 
collected over 2107.926 Hz of spectral width while the dimension 
13
C contained 204 







C dimensions were at 4.782 ppm, 119.081 ppm and 41.745 ppm respectively. 
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3D CBCA(CO)NH experiment (Grzesiek, Vuister et al. 1993) was carried out 
similarly using the same data points and spectral widths as above, except that the 
dimension 
13




 Amide proton distance constraints were derived from 3D 
15
N-edited Nuclear 
Overhauser Effect spectroscopy (NOESY) with 100 ms mixing time. Each cross-peak 
in a 
15
N-NOESY amide strip represents an NOE between amide protons to a nearby 
proton within around 5 Å distance. 1280 complex points were recorded for the 
1
H 
dimension corresponding to the directly detected 
1
H dimension over spectral width of 
11160.714 Hz. For 
15
N dimension, 104 complex points were detected over spectral 
width of 2108.370 Hz, while 232 complex points were recorded for spectral width of 
9601.536 Hz for F3 dimension (
1
H). Carrier frequencies for F1, F2 and F3 were at 
4.725 ppm, 119.081 ppm and 4.725 ppm respectively. 




N-edited NOESY of EvpP_P143T mutant 





edited large proteins expect for Nuclear Overhauser Effect spectroscopy (NOESY) 
and multi-quantum 
13
C total correlation spectroscopy (MQ-CCH-TOCSY); a new 
strategy has been developed for backbone as well as side chain assignment by 
utilizing a set of spectra: HSQC, HNCA, HN(CO)CA, 4D NEOSY and HCCH-
TOCSY.  Clusters are formed by matching HC-NH NOE and Cα-NH (on HNCA) 
correlations that have identical NH chemical shifts. Spin systems are identified by 
sorting out intra-residue and sequential HC-NH NOE correlations from other inter-




N-edtited NOESY spectrum with 
the help of HNCA and MQ-CCH-TOCSY. Clusters are linked to form amino acid 
residue chains by matching the intra-residue spin system of one cluster with the 
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sequential spin systems of other clusters. The fragments of amino acid chains can 
then be fitted into the protein sequence (Yingqi Xu, et al, 2006). 
 1280 complex points were recorded for the directly detected 
1
H dimension 
over a sweep width of 11160.714 Hz. The indirect H dimension has 104 complex 
points recorded over a sweep width of 9398.496 Hz. In the 
15
N dimension, 40 
complex points were recorded over a sweep width of 2108.370 Hz. In the 
13
C 
dimension, 40 complex points were recorded over a sweep width of 4426.737 Hz. 
Carrier frequencies of the four dimensions would be 4.782 ppm, 4.782 ppm, 119.082 
ppm and 56.745 ppm respectively. 
2.11.5 
13
C-edited MQ-CCH-TOCSY of EvpP_P143T mutant 
 3D HCCH-TOCSY experiment was utilized to identify side-chain spin 
system by connecting aliphatic 
1
H resonances with their attached 
13
C resonances 
(Wang and Zuiderweg 1995). The protein sample used in this experiment was 
prepared by exchanging 
13
C-labeled protein with deuterated buffer at pD 7 in 99.9% 
D2O. A total of 1280 complex points were collected for dimension 
1
H over 
11160.714 Hz spectral width, while in directly detected 
13
C dimension, 180 points 
over 13280.212 Hz spectral width were recorded. In the indirect 
13
C dimension, 60 
complex points were recorded over 4426.737 Hz of spectral width. The carrier 
frequencies were at 4.725 ppm, 41.742 ppm and 41.742 ppm respectively. 
2.11.6 
15
N-edited NOESY of EvpP_P143T mutant 
 This experiment was carried out under the same condition to the one carried 
out for EvpP wild type protein. 1280 complex points were recorded for the 
1
H 
dimension corresponding to the directly detected 
1
H dimension over spectral width of 
11160.714 Hz. For 
15
N dimension, 104 complex points were detected over spectral 
width of 2108.370 Hz, while 232 complex points were recorded for spectral width of 
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9601.536 Hz for F3 dimension (
1
H). Carrier frequencies for F1, F2 and F3 were at 





N heteronuclear NOE cross relaxation experiment 




N HSQC-NOE experiment, two HSQC spectra were 
recorded with an interlude, with and without proton saturation (NOEon, NOEoff). And 
the difference in peak intensities between the two spectra will describe the relaxation 
of NOE. The spectrum was acquired with 1280 complex points over a spectral width 
of 11160.714 Hz on 
1
H dimension. In the 
15
N dimension, 216 points were collected 




N were at 4.782 ppm and 119.082 
ppm respectively. 
2.12 HDX-MS (hydrogen-deuterium exchange mass spectrometry) 
 Hydrogen-deuterium exchange mass spectrometry eperiments were carried 
out in order to probe flexible and rigid part of both wild type EvpP and the 
EvpP_P143T mutant. Sample protein was exposed to 100% D
2
O buffer for various 
period of time and quenched before subjected to mass spectrometry. In order to 
increase resolution in terms of amino acid sequence, the quenched sample was 
subjected to pepsin digestion. Prior to ESI mass spectrometry, the peptides were 
seperated by an HPLC column to further increase resolution. The whole process was 




 Hydrogen Deuterium Exchange (HDS) 
System (Waters Corporation). Data were recorded and analyzed by ProteinLynx 
software, ProteinLynx Global Server (Waters Corporation) and mass spectra 
assignment was carried out using DynamX. 
2.12.1 Sample and buffer preparation 
 Purified wild type EvpP and EvpP_P143T mutant were each concentrated to 
about 50 µM before subjected to HDX experiment. Dry buffers were prepared by 
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drying the aqueous buffer (20 mM Tris-Cl, pH7.0) using a SpeedVac concentrator at 
room temperature or higher. Hundred percent deuterium oxide was added to the dry 
buffer powder only prior to HDX experiment. The quench buffer was made by 
mixing 100 µl of 2% TFA to 2.9 ml H2O. Wash buffer was made by further topping 3 
ml of quench buffer up to 5 ml by adding 2 ml of protein buffer (20 mM Tris-Cl 
pH7.0). 
2.12.2 HDX-MS of EvpP and EvpP_P143T 
 For each round of experiment, 2 µl of protein sample (at a concentration of 
50 µM) was mixed with 18 µl of D2O redissolved dry buffer (to yield a final 
concentration of 90% D2O) for different period of time before quenching (10 sec, 20 
sec, 30 sec, 1 min, 5 min, 30 min and overnight). The sample mixture was quenched 
by adding 30 µl of quench buffer (to lower the pH to around 2.5) and was 
immediately injected into the chilled nanoACQUITY UPLC sample manager. The 
sample was washed through a pepsin column and the digested peptides were trapped 
in a C18 trap (ACQUITY BEH C18, Waters Corporation). The peptides were eluted 
using an 8% - 40% gradient of acetonitrile in 0.1% formic acid at 40 µl/min 
(nanoACQUITY Binary Solvent Manager, Waters Corporation). The peptides were 
detected and their respective mass was measured on a Synapt HDMS mass 
spectrometer (Waters Corporation). 
 Sequence identification was carried out using the undeuterated samples by 
ProteinLynx Global Server (Waters Corporation) and searched against the sequences 
of both EvpP and EvpP_P143T with no enzyme specified and no amino acid 
modifications. True identifications were revognized if they appeared in both 
replicated runs. The precursor ion mass tolerance was set to < 10 ppm and the 
fragment ion tolerance was set to < 20 ppm. The spectrum intensity was set to > 3000. 




 The peptide spectra assignment of each identified peptide in undeuterated 
sample as well as in subsequent deuterated samples were carried out using the 
DynamX software. The output file was converted to a microsoft Excel format for 
further data analysis. The back-exchange constant used for calculating the exchange 
rate was 1.49. 
2.13 Glutathione-S-Transferase pull-down assay 
 Fifty microliler of glutathione-sepharose 4B beads (Amersham Biosciences) 
was added into an eppendorf tube and was washed at least 3 times by 1 ml of 1 X 
PBS each time. The GST-fusion protein of GST-EvpC (around 100 µg), or GST 
protein alone as a control, was added into the tube and the mixture was topped up to 
500 µl by 1 X PBS. The protein was incubated with the beads at 4C for at least 1 
hour. The beads were washed with 1 ml of 1 X PBS for at least 3 times. 200 µg of 
targeted protein, EvpP was added into the tube and the volume was topped up to 500 
µl by 1 X PBS. The mixture was incubated at 4C for at least 2 hour with mixing. The 
beads were washed with 1 X PBS to remove unbound or loosely bound proteins. 100 
µl of 2 X SDS sample buffer was added into the beads and the suspension was boiled 
for 5 min followed by centrifugation at 13,000 rpm for 10 min. The supernatant was 
analyzed on SDS-PAGE. 
2.14 Expression and purification of AcrH-AopB (1-264) 
 Protein expression and purification of AcrH-AopB (1-264) was carried out in 
the same way as described in Section 2.2 except that both the dialysis buffer as well 
as the FPLC buffer used were 20 mM Tris-Cl pH8.0 with 200 mM NaCl, 5% 
Glycerol and 5mM β-mercaptoethanol. The Buffer A for MonoQ ion exchange 
chromatography was 20 mM Tris-Cl pH8.0 and Buffer B was 20 mM Tris-Cl pH8.0 
with 1 M NaCl. 
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2.15 Limited protease digestion of AcrH-AopB (1-264) 
 Limited protease digestion of AcrH-AopB was carried out in the same way as 
described in Section 2.4 except that the enzymes used were elastase, thrombin, 
thermolysin, actinase E, proteinase K, clostripain and bromelain. 
2.16 Protein sequencing of digested AcrH-AopB complex 
 Protein sequencing of digested AcrH-AopB complex was carried out in the 
same way as described in Section 2.7. 
2.17 Crystalization screening of digested AcrH-AopB complex 
 The purified AcrH-AopB complex (after partial digestion by different 
enzymes) was concentrated to 10 mg/ml with an Amicon filter (Milipore, 10-kDa 
molecular weight cut-off) before crystallization.  Crystallization screening was 
carried out using Index Screens (Hampton Research) employing the hanging-drop 
vapor-diffusion technique at 302K. The drop sizes were 1 µl protein solution to 1 µl 
reservoir solution; 1 µl to 2 µl as well as 2 µl to 1 µl. The initial crystal was obtained 
within two weeks. The crystallization was further optimized by varying the pH of the 
reservoir buffer (in which previously crystals could form), the concentration of the 
protein as well as the crystallizing temperature. Preliminary diffraction pattern of 
crystal was collected with an in-house X-ray machine (Bruker MICROSTAR X-ray 





CHAPTER 3, RESULTS & DISCUSSIONS (EvpP) 
3.1  The search for candidates in T6SS for structural studies 
 
The T6SS gene cluster of Edwardsiella tarda. evp: E. tarda virulent protein; orf: open 
reading frame. (Zheng and Leung, 2007) 
 
The gene cluster of T6SS in E. tarda harbours several small proteins that 
might be potential targets for structural study, including EvpA, EvpC, EvpE, EvpJ, 
EvpL, EvpN and EvpP. However, only EvpC has a known structure which is similar 
to Hcp1. EvpC, in high concentration, forms a hexameric ring structure that can 
elongate to constitute the needle conduit of T6SS. Therefore we initially examined 
each of the small proteins other than EvpC as potential targets for structural studies. 
Each protein, either full-length or a truncation mutant, was cloned into the pET-M 
vector and tested for expression. The insoluble ones were then tested for protein 
refolding by rapid dilution. All soluble protein samples were concentrated and passed 
through FPLC (Hiload Superdex 75) to investigate their oligomeric state in solution. 
The result was shown in Table 3.1 as follows. 
Table 3.1, Expression of the small proteins in T6SS gene cluster of E. tarda 
Proteins Length Expressed Expression Solubility After Refolding 
EvpA 171a.a. Full length Medium Inclusion 
body 
Aggregation 
EvpE 158a.a. Full length High Inclusion 
body 
Aggregation 
 158a.a. 1-120 High Inclusion 
body 
Aggregation 
 158a.a. 1-135 High Inclusion 
body 
Aggregation 
EvpJ 100a.a. Full length Medium Inclusion 
body 
 





EvpL 235a.a. Full length No   
 235a.a. 54-235 No   
EvpN 216a.a. 1-182 High Inclusion 
body 
Aggregation 
EvpP 185a.a. 185 Medium Soluble  
  
EvpA, EvpE (both full length as well as two truncation mutants) and EvpN 
had a high expression yield but formed inclusion bodies. They could be refolded into 
a soluble state by rapid dilution into normal buffers which did not contain urea or 
guanidine hydrochloride at neutral pH. However all of them were aggregated in 
solution which was shown by gel filtration as they were eluted out in void volume 
(data not shown). EvpJ (full length and truncation mutant EvpJ
1-90
) showed little 
expression which also formed inclusion body. EvpL (full length and truncation 
mutant EvpL
54-235
) had no expression at all. Only EvpP was soluble by itself that did 
not require protein refolding. 
 This result was not surprising as EvpP was found to be a secreted protein 
therefore it should have a higher propensity to be soluble by itself. On the other hand, 
the others were generally thought to be apparatus proteins that might need the 
presence of binding partners to reach a stable state. In addition, they may require 
chaperones for proper expression to prevent pre-mature association before meeting 
their interacting partners. As EvpP was exclusively found in Edwardsiella species 
and contributes to pathogenic virulence, it is a very interesting target for structural 
studies in T6SS. 
3.2 Characterization of EvpP 
 EvpP (from E. tarda strain 130/91) is 185 amino acid residues in length, 20.3 
kDa in molecular weight with a theoretical pI of 9.47. His-tagged EvpP (cloned in 
pET-M expression vector) was over-expressed in E. coli BL21 (DE3) as a soluble 
protein that could be further purified through Ni-NTA affinity column. The purified 
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EvpP protein was then passed through a Superdex 75 gel filtration column and it was 
eluted out around 72 mins at a speed of 1 ml/min (Figure 3.1). This showed that EvpP 
is not an aggregation and it could exist as a monomer in solution. 
 
Figure 3.1, Expression and FPLC profile of EvpP (130/91). Bi: before induction; Ai: after 
induction; P: pellet; S/N: supernatant. 
 
 EvpP did not contain any signal sequence at the N-terminus (by SignalP 4.1 
server) and no hydrophobic patch was found throughout its sequence. The secondary 
structure prediction showed that EvpP is not a well-structured protein; as more than 
half of the protein was predicted to be random coils (Figure 3.3). The circular 
dichroism spectra of EvpP under different pH (ranging from pH4 to pH8) also 
showed a pattern that is neither typical of α-helices or β-strands. However EvpP does 
have higher order structures as the spectra significantly differ from the pattern of a 




N HSQC of EvpP (Figure 3.4). 
 




Figure 3.3, Secondary structure prediction of EvpP (by PSIpred 3.0 server, UCL 
Department of Computer Science) 
 
 The CD spectra showed that the secondary structure of EvpP remained 
unchanged across all the tested pH. The CD spectrum under pH4 partially deviated 
from the others, which might be due to the acidic pH where proteins started to lose 
their secondary structure. As the pI of EvpP was predicted to be 9.47; the CD spectra 
from pH5 to pH8 all converged to show a common trend. Therefore neutral pH (pH7) 
was used for further experiments with EvpP. 
 As EvpP failed to form any kind of crystal either under room temperature or 





N-edited HSQC of EvpP was recorded using a Bruker AVANCE 800 MHz 
NMR spectrometer and processed HSQC was shown in Figure 3.4. As the His-tag 
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was proved difficult to remove by thrombin cleavage, EvpP with His-tag was used for 
NMR studies. 90 separated cross-peaks could be counted from the HSQC (not 
counting side chain cross-peaks and very weak cross-peaks) out of a total of 203 
amino acid residues of EvpP with His-tag. Since EvpP is not a well-structured protein 
forecast by secondary structure prediction, we hypothesized that it was the structured 
portion of EvpP that showed up on the HSQC spectrum while the flexible regions 
could not be observed. The dispersion of cross-peaks on the HSQC has further 






N HSQC of EvpP. 90 separated cross-peaks could be observed on the 
HSQC (excluding side chain cross-peaks and very weak ones) out of a total of 203 amino acid 
residues of EvpP with His-tag. Each cross-peak could potentially represent one amino acid 
residue of EvpP. 
 
 EvpP was found to have a poor thermo-stability, over 90% of the protein 
precipitated out at 35°C. It could routinely precipitate at room temperature or slightly 
lower temperatures. Therefore it had to be stored at a low temperature such as 4°C. 
EvpP was also found to go through degradation over time. This occurred even at low 
temperature if given a long time period of up to a few weeks. 
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3.2.1 EvpP as a possible dimer in solution 
 Dynamic light scattering (DLS) has been a fast and reliable tool to study the 
oligomeric state of proteins in solution. Based on the FPLC profile alone, it is 
difficult to differentiate whether EvpP is a monomer or dimer in solution. At 20°C, 
EvpP showed a dimeric profile. The hydro-dynamic radius was detected to be 2.95 
nm and the corresponding molecular weight was estimated to be 44.4 kDa, which is 
twice the molecular weight of EvpP with His-tag. The homogenicity histogram was 
shown in Figure 3.5. The great majority of EvpP was found to constitute a 
homogenous species with a hydro-dynamic radius around 2.95. Two minor species of 
larger entities were also present in the solution. 
 
Figure 3.5, Histogram showing the homogenicity of EvpP at 20°C. Most of EvpP were 
found to be the dimer form, with a small portion adopting higher oligomeric states. 
 
 The formation of dimer was found in both low (10 µM) and high (500 µM) 
concentrations of EvpP. At a high concentration (500 µM) measured by NMR, the 
15




N two-spin decay NzHz of around 40 ms 
and a T1ρ around 44 ms. Both observations demonstrated a possible dimer formation 




 To further verify the dimeric state of EvpP in solution, protein cross-linking 
assay was performed on wild-type EvpP. Freshly made 2.3% glutaraldehyde was used 
to cross-link EvpP at a concentration of 50 µM. The reaction was incubated at room 
temperature instead of 37°C, as EvpP readily precipitate at that temperature. To 
compensate for that, the duration of incubation was lengthened and the trend of cross-
linking was monitored by SDS-PAGE (Figure 3.6). 
 
 
Figure 3.6, Cross-linking assay of EvpP using glutaraldehyde. From left to right, Lane 1: 
molecular weight marker; Lane 2, un-crosslinked EvpP; Lane 3 to Lane 6, EvpP incubated 
with glutaraldehyde for different period of time: Lane3, 15 min; Lane 4, 30 min; Lane 5, 45 
min; Lane 6, 1 hour. 
 
 As time progressed, more EvpP was cross-linked to the dimeric form which 
showed up as another band of higher molecular weight than the EvpP monomers. As 
expected, the intensity of the band corresponding to the dimeric form increased in a 
progressive manner with more incubation time. Some higher oligomeric order species 
of EvpP started to appear after 30 min of cross-linking. One thing worth noticing was 
that even after one hour of reaction, the majority of EvpP still remained in the 
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monomeric form on SDS-PAGE. This indirectly implied that the observed dimer of 
EvpP might not be physiological, or the dimers formed were not strong enough to be 
easily cross-linked chemically. 
3.3 Limited proteolysis showed a coherent protease-resistant core-region 
 The HSQC of EvpP as well as the secondary structure prediction both 
pointed to the fact that EvpP may contain a large portion of intrinsically disordered 
region. We speculated that EvpP has both rigid regions that are well-structured (those 
will show up on the HSQC) and flexible regions that may be involved in functional 
interactions. In order to verify this hypothesis and to further map out the rigid and 
flexible regions on EvpP, we performed limited protease digestion on EvpP using 
different enzymes. The digestion patterns of EvpP with trypsin, chymotrypsin, 
elastase and thermolysin were shown in Figure 3.7 and Figure 3.8. As trypsin reliably 
digested EvpP and generated a stable band around 10 kDa and another smeary species 
of lower molecular weight; it was used as a control for comparison among different 
proteases. More enzymes other than the four above were also tried on EvpP, such as 
papain, actinase E, proteinase K, etc. However they either failed to digest EvpP, or 
they failed to yield a convergent digestion pattern after repetitive trials. 
 
Figure 3.7, Limited protease digestion of EvpP using Trypsin, Chymotrypsin and 
Elastase. From left to right, Lane 1, molecular weight marker; Lane 2, undigested EvpP; Lane 
3 to Lane 5, EvpP digested by trypsin (1:100) for 20 min, 40 min and 60 min; Lane 6 to Lane 
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8, EvpP digested by chymotrypsin (1:100) for 20 min, 40 min and 60 min; Lane 9, EvpP 
digested by elastase (1:100) for 20 min. 
 
Figure 3.8, Limited protease digestion of EvpP using Trypsin, Thermolysin and 
Chymotrypsin. From left to right, Lane 1, molecular weight marker; Lane 2, undigested EvpP; 
Lane 3 to Lane 6, EvpP digested by trypsin (1:200) for 15 min, 30 min, 45 min and 60 min; 
Lane 7 to Lane 10, EvpP digested by thermolysin (1:200) for 15 min, 30 min, 45 min and 60 
min; Lane 11 to Lane 14, EvpP digested by chymotrypsin (1:200) for 15 min, 30 min, 45 min 
and 60 min. 
 
 As shown in Figure 3.7 and 3.8, limited protease digestion by four enzymes 
generated four different patterns. Trypsin efficiently digested EvpP and left a band 
which was around 10 kDa in molecular weight and a smeary species of lower 
molecular weight. The digestion of EvpP by trypsin was not in a time-dependent or 
progressive manner like the other three enzymes. More importantly, the digestion 
pattern of EvpP by trypsin was stable over time, as shown in SDS-PAGE, there was 
no decay in band intensity. This was not found in all other enzymes. Through 
chymotrypsin and elastase, all EvpP proteins were eventually completely digested 
after 60 minutes of incubation at room temperature. Thermolysin was not effective in 
digesting EvpP. However, if the concentration of thermolysin was raised to 1:50 in 




Among all four digestion patterns, there was always one band with a 
molecular weight of approximately 10 kDa that remained undigested. The protease-
resistant 10 kDa band in trypsin-digested EvpP had sightly lower molecular weight 
than those digested by the other three enzymes. Although the protease-resistant 10 
kDa pieces differ from each other slightly; their presence across all four digestion 
patterns have led to the speculation that there could be a structured core region of 
EvpP that is around 10 kDa. 
 Obviously, it is intriguing to find out the identity of the protease-resistant 
region of EvpP. In our attempt, we performed N-terminal sequencing for all the 10-
kDa protease-resistant pieces digested by the four enzymes that were shown on SDS-
PAGE. The bands on SDS-PAGE after limited proteolysis by each enzyme were first 
immuno-blotted onto PVDF membrane (immobilized) before being subjected to 
coomassie-blue staining and N-terminal sequencing. The 10 kDa piece after trypsin 
digestion was found to have an N-terminal sequence of GSELMSILN. The one after 
thermolysin digestion was found to have an N-terminal sequence of LVPRG. The 
ones after chymotrypsin and elastase digestion were found to have the N-terminal 
sequence of MHHHH. The results were summarized in the following diagram as 
shown in Figure 3.9. 
 
Figure 3.9, Schematic diagram showing the first 40 residues of His-tagged EvpP and the 
results of N-terminal sequencing of the 10 kDa bands after digestion by all four enzymes. 
 
 As shown in Figure 3.9, all the protease-resistant pieces that had a molecular 
weight around 10 kDa after limited proteolysis were found to start from the His-tag 
58 
 
region which precedes the N-terminus of EvpP. This suggested that it was the N-
terminal half of EvpP that was resistant to limited protease digestion and this region 
was supposed to contain the structured part of EvpP. In order to map out the 
boundaries of the protease-resistant regions of EvpP after trypsin digestion, we 
determined the molecular weight of the 10-kDa band and the lower smeary species by 
ESI-MS. The reason for choosing trypsin was because, only trypsin digested EvpP 
generated a consistent and stable pattern that could be purified for molecular weight 
determination by mass spectrometry. To determine the molecular weight of the two 
components generated by trypsin limited proteolysis, trypsin-digested EvpP was first 
purified by FPLC (Hiload Superdex 75) to remove any residual enzymes (Figure 
3.10). It was surprising that the upper band could not be separated from the smeary 
species by either FPLC or MonoQ ion exchange chromatography. This might imply 
that even after trypsin digestion, the two parts were still associated with each other so 
that they would always be co-purified and co-eluted. 
 
Figure 3.10, FPLC profile of trypsin-digedted EvpP. The peak eluted at 72 minutes was 
found to contain both the upper 10-kDa piece as well as lower molecular weight smeary 
species. 
 
The upper band was found to have a molecular weight of 9,614 Da. Together 
with the N-terminal sequencing result, we mapped the upper band of trypsin digested 
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EvpP to be from the N-terminus of EvpP to residue Arg85 (Figure 3.11). The lower 
m.w. species after trypsin digestion was found to have a molecular weight of 4,121 
Da. We also attempted to sequence this lower smeary piece, however it did not yield 
meaningful result through N-terminal sequencing. Instead, we performed peptide 
identification for the lower molecular weight species of EvpP digested by trypsin 
using MALDI-TOF-TOF tandem mass spectrometry. Through MALDI-TOF-TOF, 
two peptides were picked up and their molecular weights were found to match the 
sequences of EvpP: ENWSSLDHLLEIVLK and VPVYAWFGGFK. Therefore the 
boundaries of lower species after trypsin digestion should be around the regions 
containing the above peptides. Taken together with the molecular weight of the 
smeary species at 4,121 Da, we were able to map it from residue Ile106 to residue 
Gly141 (Figure 3.11). 
 
Figure 3.11, Sequence of EvpP. The boundaries of protease-resistant regions after 
limited proteolysis by trypsin were boxed. 
 
 Although EvpP after limited proteolysis by chymotrypsin, elastase or 
thermolysin may have slightly different boundaries from the one shown for trypsin; 
they inevitably suggested that the N-terminal half of EvpP is more rigid, in the sense 
that it is more resistant to proteolysis while the C-terminal half is not as rigid. 
3.3.1 The protease-resistant “core” of EvpP is not structurally stable 
 The trypsin-digested EvpP provided an alternate candidate for structural 
studies as it contains the rigid “core” of EvpP and has fewer residues. Therefore we 




N HSQC for trypsin digested EvpP after purification through 
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MonoQ ion exchange chromatography (Figure 3.12). By overlaying the HSQC of 
trypsin-digested EvpP against the one of full-length EvpP, we noticed that after 
limited proteolysis by trypsin, EvpP still retained its global structure. Although most 
of cross-peaks had slightly different chemical shifts, the global pattern of dispersion 
was unchanged according to the HSQC (Figure 3.13). However, during an attempt to 




C-edited CBCA(CO)NH and HNCACB spectra, trypsin-
digested EvpP lost its structure and significant precipitation was observed in the 
NMR tube after a three-day experiment at 20°C (Figure 3.14). Although the protease-
resistant core of EvpP (after limited proteolysis by trypsin) still retained its tertiary 











Figure 3.13, Overlay of HSQC acquired from trypsin-digested EvpP against full length 











 As EvpP readily precipitate at temperatures of 35°C or higher, making 
thermal denaturation unfeasible, we performed urea denaturation experiments 
measured by a fluorescence spectrometer comparing both intact as well as trypsin-
digested EvpP (Figure 3.15). As expected, after limited proteolysis by trypsin, EvpP 
was more susceptible to unfolding by urea denaturation compared to the full-length 
EvpP. The estimated Gibb’s free energy for wild-type EvpP was fitted at 10.619 
kCal/mol, with an m value of 0.80 towards urea denaturation. Trypsin digested EvpP 
on the other hand, had a ∆G of 8.261 kCal/mol, which was significantly lower than 
wild-type EvpP. The estimated m value was 1.23, which was also larger compared to 
wild-type EvpP. It was worth-noticing that the full-length EvpP already showed traits 
of unfolding before the transition state at 5 M of urea concentration.  
 
Figure 3.15, Urea denaturation measured by fluorescence spectrometry. Curve fitting was 
performed using Kaleidagraph ver4.0 
 
 Limited proteolysis by various enzymes has generated a relative consensus 
about the core region of EvpP, which is resistant to protease digestion. Among all 
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enzymes that were used, trypsin yielded a stable digestion pattern consisting of a 
9,614-Da piece and a 4,121-Da smeary species. The band around 10 kDa was 
observed in all protease-digested patterns while the 4 kDa species was not. However 
the 4 kDa species always remained attached to the 10 kDa piece, forming a quasi-
stable complex that could be co-purified and co-eluted through FPLC or ion exchange 
chromatography. Although this trypsin-digested EvpP is not as stable as the full-
length protein; by acquiring an initial HSQC (before it starts to unfold), we learned 
that the structured regions of EvpP are largely located within the trypsin-digestion 
mapped boundaries. 
3.4 NMR backbone chemical shift assignment for wild type EvpP 
 As the trypsin-digested EvpP is not stable for structural study; we attempted 




C edited CBCA(CO)NH and HNCACB spectra for backbone 
assignment using wild-type EvpP. Due to the dimeric feature and the resultant fast 




C-edited samples are not sensitive enough. Therefore deuterated EvpP samples were 
used to acquire these spectra. E. coli cells that carry plasmids expressing EvpP were 
allowed to grow in M9 minimal media prepared from 100% D2O. After the cells were 
harvested, deuterated EvpP proteins were purified by Ni-NTA affinity column and 
FPLC using a normal aqueous buffer so that the backbone amide protons can be 
exchanged back to hydrogen. The sample was concentrated to around 700 µM for 
both 3D experiments. Through 3 days experiment at 20°C, persistent precipitation 
was observed in the NMR tube; however the remaining EvpP still retained its 
structure shown by a final HSQC acquired at the end of the 3D experiments.
 Backbone chemical shifts were assigned using a pair of HNCACB and 
CBCA(CO)NH triple resonance experiments. First, we correlated all the amide-
proton cross-peaks (on the HSQC) with the Cα and Cβ resonances of the same 
residue using the HNCACB spectrum. Next, CBCA(CO)NH spectrum was used to 
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correlate the amide-proton cross peaks with the Cαi-1 and Cβi-1 of its preceding residue. 
The amide-proton cross-peaks were then linked together to form backbone fragments 
by matching chemical shifts of Cα and Cβ from one residue with the Cαi-1 and Cβi-1 
from another residue, or vice versa. An example of such backbone linkage was shown 
in Figure 3.16, exhibiting residues S2 to N5. The backbone fragments were then fitted 
into the sequence of EvpP aided by the signature Cα and Cβ chemical shift values of 
typical amino acids as starting points. For example, Ser and Thr residues have unique 
Cβ chemical shift values that are higher than their Cα. Another typical residue used 
for initial fitting is Ala, owing to its unique Cβ chemical shift value that usually 
appeared at ≤20 ppm, which is much lower than other residues. Finally, Gly residues 
were also particularly helpful as it only has a Cα cross peak appearing in the 
HNCACB spectrum. 
 
Figure 3.16, Sequential assignment of backbone chemical shifts of EvpP using a 
deuterated sample. Lanes marked by “i” were the corresponding HNCACB spectrum amide 
strips; Lanes marked by “i-1” were the corresponding CBCA(CO)NH spectrum amide strips. 
 
 Using this method, we were able to unambiguously assign 41 cross-peaks 
(out of 88, total number of cross-peaks) on the HSQC into the amino acid sequences. 
There were more backbone linkage fragments being identified. However they did not 
have characteristic Cα and Cβ chemical shifts like Ser, Thr or Ala residues. Therefore 
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we could not fit them into a particular EvpP amino acid sequence due to the lack of 
information. The assigned residues were shown in Figure 3.17 and they were mapped 
onto the sequence of EvpP in Figure 3.18. 
 








Figure 3.18, Sequence of EvpP with the assigned residues by HNCACB and 
CBCA(CO)NH mapped out in pink; the trypsin-digestion boundary was marked by red 
box. 
 
 As shown in Figure 3.18, almost all the assigned residues fell within the 
trypsin-digestion boundary, which agreed with our previous hypothesis that the 
trypsin-resistant core of EvpP harbours the structured regions of EvpP. Three other 
residues were found outside the boundary. As they no longer showed up on the 
HSQC of the trypsin-digested EvpP, they still agreed with our hypothesis. More 
importantly, most of the assigned residues were found to be at the N-terminus of 
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EvpP. This also supported our speculation that the N-terminal half is more rigid than 
the C-terminus. The assigned stretches were mainly composed of three to five 
residues only. This was due to the incomplete set of information gathered from the 
Cα and Cβ chemical shifts of wild-type EvpP. 
Now we were facing one problem. We’ve already deuterated EvpP and thus 
far, only half of the cross-peaks on the HSQC could be assigned. Therefore to obtain 
a more complete backbone chemical shift assignment, we definitely need a better 
construct that gives stronger signal than wild-type EvpP. 
3.5 The search for stable mutant of EvpP, P143T 
 Previously, several truncation mutants of EvpP were designed according to 
the secondary structure prediction. They were sub-cloned into pET-M expression 
vectors and tested for expression. In all cases, the C-terminal residues were removed 
in the truncation mutants as the N-terminal half accounted for most of the structure of 
EvpP (Figure 3.19). However, all the resultant mutants were found to be insoluble as 
they inevitably fell into inclusion bodies after being expressed in E. coli BL21 (DE3) 
competent cells. Although some of them could be refolded to obtain a portion of 





Figure 3.19, Boundaries of truncation mutants designed for EvpP marked against the 
sequence of EvpP with secondary structure prediction. 
 
 These truncation mutants were further cloned into vectors that contained 
solubility enhancement tags such as pET32a (bearing a thioredoxin tag) and pGEX-
4T-1 (bearing a glutathione-S-transferase tag). However none of the recombinant 
truncation mutants turned out to be soluble. 
 We therefore explored other possibilities for making stable mutants of EvpP. 
As EvpP is exclusively found in E. tarda and some E. ictaluri species; we analyzed 
individual EvpP across different species of Edwardsiella (Yang M, et al, 2012). 
Shown in Figure 3.20, EvpP was found present in T6SS among all the five 
Edwardsiella species. The gene cluster make-up was essentially the same for all five 
species; but, there were subtle differences in between. For example, in the T6SS of 
some species, EvpP has a longer sequence (as in E. tarda species EIB202 and 
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080813), while in the others, the sequence is significantly shorter (as in E. tarda 
species FL6-60 and E. ictaluri species 93-146 and ATCC33202). 
 
Figure 3.20, T6SS gene cluster from 5 Edwardsiella species. EIB202, FL6-60 and 080813 
were Edwardsiella tarda species; 93-146 and ATCC33202 were Edwardsiella ictaluri species. 
 
 The E. tarda strain we were working with (130/91) belongs to the EdwGI 
type and the sequence alignment of EvpP among different species showed that our 
EvpP is a longer form, with particular differences if compared to other long-form 
EvpP proteins (Figure 3.21). 
 
Figure 3.21, Sequence alignment of EvpP among different E. tarda species. The one from 
Aeromonas species was possibly due to horizontal gene transfer from EIB202 (Xin, W, et al, 
2009). 
 
 The sequence alignment clearly showed that EvpP is well conserved among 
all strains of Edwardsiella tarda. The overall sequence identity is 87%. Among them, 
strain FL6-60 has a shorter form of EvpP compared to other strains of E. tarda; 
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implying that there is a closer phylogenetic relationship to the E. ictaluri species 
because they tend to have shorter forms of EvpP (as shown in Figure 3.20). 
 EvpP from strain 130/91 is much different compared to the strains EIB202 
and 080813, even though all three strains have long-form EvpP. EvpP from EIB202 
and 080813 are very similar. They share more than 96% sequence identity and they 
both have 187 amino acid residues. Compared with these two strains, EvpP from 
130/91 has a slightly shorter sequence of 185 amino acid residues. More importantly, 
it contains sequence variations in several well-conserved positions, namely Pro20, 
Leu34, Pro58, Leu91, Pro143 and Gly156 (Figure 3.21, marked red). In the above 
positions, all other EvpP proteins are identical while only EvpP from 130/91 has an 
alternative residue where these sequence variances are not conserved in terms of 
amino acid property (alanine to proline, glutamine to leucine and threonine to proline). 
Another noteworthy finding about EvpP from 130/91 is that, it contains significantly 
more proline residues than other strains. 
 It was intriguing to investigate each of the individual single residue point 
mutations on EvpP and the stability of resultant mutants. We mutated EvpP protein 
(strain 130/91) at the above positions and changed the amino acid residues to the 
conserved ones as in other strains of E. tarda to construct six single mutants, namely 
P20A, L34Q, P58S, L91Q, P143T and G156S. We have also attempted to sub-clone 
and express the wild-type EvpP protein from strain EIB202. Unexpectedly, the 
protein turned out to be insoluble after being over-expressed in E. coli BL21 (DE3) 
competent cells. Therefore we continued our research on EvpP (130/91) by 
investigating the stability of its single-residue mutants. 
3.5.1 Characterization of the mutant EvpP_P143T 
 Six mutants (P20A, L34Q, P58S, L91Q, P143T and G156S of EvpP) were 
sub-cloned and tested for expression. Among them, L34Q did not show any 
expression. P20A, L91Q and G156S were found to have expression but they formed 
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inclusion bodies. P58S and P143T were found to have good expression and similar 
solubility compared to wild-type EvpP (Figure 3.22). 
 
Figure 3.22, Expression profile of different single residue mutants of EvpP. P: pellet; S/N: 
supernatant. Among all 6 mutants, L34Q did not have expression (data not shown); P20A, 
L91Q and G156S were expressed but not soluble; P58S and P143T could be expressed and 
were soluble by themselves. 
 
 Mutant proteins of P20A, L91Q and G156S were solubilized and purified in 
buffers containing 8 M urea. They were later refolded back into buffers containing 20 
mM Tris pH7.0 with no denaturing agent. We compared the stability of each of the 
individual mutants as well as the wild-type EvpP by urea denaturation experiments 
measured by fluorescence spectrometry (Figure 3.23). 
 
Figure 3.23, Urea denaturation of wild type of EvpP compared to 5 of its mutants. Curve 




 Shown in Figure 3.23, mutants P20A, P58S and G156S had similar stability 
towards urea denaturation like wild-type EvpP. The mutant L91Q was less stable, as 
the observed transition state was earlier than wild-type EvpP. Although the ∆G of 
L91Q was estimated to be 10.863 kCal/mol, which was comparable to wild-type 
EvpP (10.619 kCal/mol); the estimated m value for L91Q was much larger than wild-
type EvpP (0.80) at 1.17. As leucine is a hydrophobic residue that might be buried in 
the structure of EvpP, it could be involved in forming hydrophobic interactions with 
other hydrophobic residues inside the “core” region. Once changed to a hydrophilic 
residue glutamine, such interaction would be disrupted, resulting in decreased 
stability of the protein. Interestingly, the mutant P143T showed an increased stability 
towards urea denaturation. It was estimated to have higher ∆G (11.15 kCal/mol) and 
lower m value (0.66) compared to those of wild-type EvpP. Threonine is a brunched 
amino acid with a polar side chain. It has a higher propensity to form interactions 
with the other residues compared to proline, which does not have a side chain. Proline 
has a few amino acid preferences for interaction, typically with aromatic residues like 
tryptophan or tyrosine, while threonine does not have such preference (Guilhem F, et 
al, 2008). Therefore new intra-molecular interactions formed by this mutation may be 
the reason for the improved stability of EvpP_P143T mutant protein. This has 
prompted us to further characterize P143T as a stable EvpP mutant. 
 EvpP mutant P143T has a similar molecular weight to the wild type. It was 
also eluted around 72 minutes through a Hiload Superdex 75 gel filtration column. 
Experiments by DLS showed that mutant P143T particles in solution had a 
hydrodynamic radius of 2.78 nm and an estimated molecular weight of 35.6 kDa. 
This was slightly less than the observed dimeric molecular weight of wild-type EvpP 
by DLS. However the estimated NzHz and T1ρ remained unchanged in P143T mutant, 
suggesting similar molecular movement compared to wild-type EvpP. 
 Limited protease digestion of P143T by trypsin has generated a slightly 
different pattern compared to wild-type EvpP (Figure 3.24). Before the digestion 
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came to a stable pattern (whereas wild type depicted a 10 kDa band and a lower 
smear of 4 kDa), there was an intermediate band that had a slightly higher molecular 
weight than the 10 kDa band. Although this band was soon digested and converged 
with the stable 10 kDa band; it nevertheless indicated a slower digestion pace of 
P143T compared to wild-type EvpP. This reduced pace of limited proteolysis might 
come from the increased intrinsic stability of mutant P143T. 
 
Figure 3.24, EvpP_P143T digested by trypsin (1:100). Lane 1, molecular weight marker; 
Lane 2 to Lane 5, EvpP mutant P143T digested by trypsin for 5 min, 10 min, 30 min and 60 
min. 
 
 Mutant P143T also showed similar patterns after limited digestion by 
chymotrypsin, elastase and thermolysin (Figure 3.25). In all cases, it showed a slower 
“pace” towards proteolytic cleavage, which could be partially accounted by the 








Figure 3.25, Limited protease digestion patterns of EvpP mutant P143T by 
chymotrypsin, elastase and thermolysin compared to wild type. Panel A, chymotrypsin 
digestion pattern of P143T and wild type EvpP; Panel B, elastase digestion pattern of P143T 
and wild type EvpP; Panel C, thermolysin digestion pattern of P143T and wild type EvpP. 
 
3.6 Backbone assignment of EvpP_P143T 
 EvpP mutant P143T showed another significant improvement in protein 
stability, as it could be kept at 20°C at a concentration of around 800 µM for more 
than a week before starting to precipitate. Wild-type EvpP could not last so long since 
previously we conducted the NMR triple resonance experiments HNCACB and 
CBCB(CO)NH within 3 days. Wild-type EvpP readily formed a significant amount of 
precipitation during the experimental process. This allowed us to re-investigate the 
backbone assignment of EvpP (P143T) using a 4D NMR strategy that requires a total 






C-edited HNCA, HN(CO)CA, and 
4D-NOESY as well as a 
13
C-edited CCH-TOCSY. 
 The 4D strategy was designed for backbone and side chain assignment of 
large proteins without deuteration (Yingqi, X, et al, 2006). Although most of the 





proteins (more than 25 kDa in molecular weight) due to their short relaxation time; 
experiments based on Nuclear Overhauser Effect (NOE) and multi-quantum 
13
C-
edited total correlation spectroscopy (MQ-CCH-TOCSY) do not rely too much on the 
relaxation rate. Previously owing to the dimeric characteristic of EvpP (also its 
mutant P143T) and the resultant short relaxation time, through-bond triple resonance 
experiments failed to yield a decent signal-to-noise ratio. However a through-space 
experiment, 
15
N-edited NOESY, generated a moderate spectrum for EvpP. Therefore 
it was worth trying the 4D strategy on EvpP mutant P143T, which was able to 








 Firstly, clusters were formed by grouping HSQC, HNCA, HN(CO)CA and 
4D-NOESY correlated peaks according to their unique NH chemical shifts; as NH 




H. In most cases, each individual cluster would 
represent one amino acid residue of the backbone sequence. This step was relatively 
non-ambiguous as both HNCA and HN(CO)CA did not contain many overlapping 




H chemical shifts), HCαi-NH and HCαi-1-NH NOE peaks usually had strong peak 
intensities (Figure 3.27). 
 
Figure 3.26, Cluster identification by correlating individual cross-peaks on the HSQC to 





H. Panel A, corresponding amide strip of residue I3 on HNCA; Panel B, corresponding 
amide strip of residue I3 on HN(CO)CA; Panel C, HSQC of EvpP_P143T, the cross-peak 





Figure 3.27, Cluster identification following grouping correlated peaks from HSQC, 
HNCA and HN(CO)CA; the HNCA peaks were reflected on the 4D-NOESY plane 




H. Panel A, corresponding amide strip of residue I3 on 
HNCA; Panel B, 4D-NOESY plane (XY plane) of residue I3 located by the amide NH 
chemical shifts in Axis A and Axis Z. Both Cαi and Cαi-1 could be found on the 4D-NOESY 
plane that had identical 
13
C chemical shifts. 
 
 The second step is to identify the two spin systems within each cluster, one 
belongs to its own residue and the other belongs to its preceding residue. From CCH-




H spin pairs of various individual HC-NH NOEs, 
the CCH-TOCSY pattern of each NOE peak on the 4D-NOESY plane could be 
extracted. Those NOE peaks that gave rise to similar CCH-TOCSY patterns within 
which one of the 
13
C chemical shift was identical to the HαCα-NH NOE or one of the 
HNCA peaks (previously identified clusters), were grouped into one spin system 
defined by that corresponding HNCA peak. Using this method, all intra-residue and 
sequential HC-NH NOE peaks within each cluster (representing a particular amino 





edited 4D-NOESY spectrum. During the same process, an intra-residue and a 
sequential spin system could be established for each cluster. In addition, the amino 





chemical shifts (Figure 3.28 and 3.29). Note that on the 4D-NEOSY plane, the side 
chain 
13
C chemical shifts were usually folded as the observed spectral width was set 
to 22 ppm. Therefore the polarity of each HC-NH NOE peaks would be reversed each 
time the 
13





Figure 3.28, Spin system identification of residue I3 for its intra-residue NOE peaks. 




H; Panel B to 
Panel E, corresponding CCH-TOCSY slices of individual intra-residue HC-NH NOEs on the 
4D-NOESY plane: HCαi-NH, HCβi-NH, HCδ1-HN and HCγ2-NH. 
 
 
Figure 3.29, Spin system identification of residue I3 for sequential (i-1) NOE peaks. Panel 




H; Panel B and C, 
corresponding CCH-TOCSY slices of individual sequential HC-NH NOEs on the 4D-NOESY 
plane: HCαi-1-NH and HCβi-1-NH. 
 
 Spin system identification was the rate-limiting step for backbone assignment. 
As the sole reference for grouping NOEs into a spin system, CCH-TOCSY spectrum 
was often crowded with overlapping problems due to the large number of amino acid 
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residues in protein sequence. Secondly, many clusters simply didn’t have enough 
NOEs on the 4D-NOESY or the NOE peaks on the 4D-NOESY had very poor signal-
to-noise ratio. This was further complicated by the presence of inter-residue NOEs 
where some of them were rather strong on the 4D-NOESY spectrum. 
 The next step is to link different clusters to form fragments and map the 
fragments to the sequence of EvpP_P143T. Intuitively, two clusters were compared 
with each other to examine whether they could construct a dipeptide from the two 
consecutive clusters. The dipeptides were further linked with other clusters to form 
longer fragments, which were finally mapped into protein sequence. Usually two 
consecutive clusters A and B would fulfill the following criteria (Zheng Yu, PhD 
thesis, development of NMR methods for the structural elucidation of large proteins): 
1. The HNCA peak Cαi of A should have same 
13
C chemical shift value with the 
Cαi-1 of B, or vice versa (Figure 3.30). 





chemical shift values with the Hαi-1Cαi-1-NH NOE of B, or vice versa (Figure 
3.31). 




Figure 3.30, Cluster mapping: amide strips on HNCA from residue I3 and its preceding 





Figure 3.31, Cluster mapping: the 4D-NOESY planes of residue I3 and its preceding 
residue S2 were compared. The HCαi-1-NH NOE peak of residue I3 matched the HCαi-NH 
NOE peak of residue S2. The HCβi-1-NH NOE peak of residue I3 matched the HCβi-NH NOE 
peak of residue S2. They both had sequential NOEs coming from the NH of each other. 
 





edited HSQC. Almost all the peaks on the HSQC could be assigned to EvpP_P143T 
sequence except for a few that had very weak signal in both HNCA and 4D-NOESY 
spectra. The assigned residues were labelled out on the HSQC. Some of the cross-
peaks were found to come from the Histidine-tag preceding the N-terminal sequence 












C-edited EvpP_P143T, with the assigned residues 
labelled out. Some of the peaks (usually with very strong signal intensity) were found to 
come from the His-tag preceding EvpP_P143T amino acid sequence. These peaks were not 
labelled in the above HSQC. 
 
 The assigned residues were mapped on the sequence of EvpP-P143T against 
the trypsin digestion boundary (Figure 3.33). The great majority of peaks (80 of them) 
were found to be within the trypsin-digestion boundary, which agrees with our 
previous hypothesis. The assignment was almost complete for the N-terminal half 
except for a few unassigned residues. Also, the presence of nine proline residues 
further broke the assigned amino acid chains into fragments. There was a gap of 
assignment from residue Tyr47 to residue Pro59, suggesting a possible internal region 
of flexibility within the N-terminal half of EvpP_P143T. 
 
Figure 3.33, Sequence of EvpP_P143T with the assigned residues mapped out in pink; 




 On the other hand, nine assigned residues were found outside the trypsin-
digestion boundary. Among them, the C-terminal stretch “VGH” was still found 
present on the HSQC acquired for the trypsin-digested EvpP (Figure 3.12), while the 
others did not show up any more. In order to account for the presence of these 
residues on HSQC even after trypsin digestion, we examined the residues “VGH” and 
found that they were forming long range NOEs with residues on the N-terminal half 
of EvpP_P143T. Specifically, residue V173 had long-range NOEs with residue T64 
(Figure 3.34) while residue G174 had long-range NOEs with residue D62 (Figure 
3.35). Both residues T64 and D62 were located at the N-terminal half of EvpP_P143T 




Figure 3.34, 4D-NOESY planes of residues T64 and V173 were shown next to each other 





Figure 3.35, 4D-NOESY planes of residues D62 and G174 were shown next to each other 
with the inter-molecular long range NOEs marked out between these two residues. 
 
 Therefore it was logical to speculate that the C-terminal stretch “VGH” could 
be forming interactions with the N-terminal half of EvpP_P143T, probably at the 
region from residues D62 to T64. Such interaction would protect these residues from 
limited proteolysis by trypsin and after digestion, they could still be observed on the 
HSQC. However, they could not be detected on the SDS-PAGE of trypsin-digested 
EvpP. As in a denaturing condition, the interaction between these two regions would 
be disrupted and this C-terminal stretch was too short to be visible on the SDS gel. 
3.6.1 Heteronuclear NOE experiment on EvpP mutant P143T 
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 To further verify that residues showing up on the HSQC of EvpP account for 
the rigid regions, we performed heteronuclear NOE experiment using 
15
N-edited 




N NOE experiment was carried out in an interleaved manner, with and without 
proton saturation (NOEon, NOEoff).  
 




N heteronuclear NOE spectra. Peaks from the 
experiment without proton saturation were shown in green while peaks from the proton-
saturated experiment were shown in red. The decrease in observed peak intensity described 
the flexibility of that particular residue. 
 
The two HSQC-like spectra were overlaid for peak intensity comparison 
(Figure 3.36). With proton saturation, decreases in peak intensities of individual 
residues ranged from 20% to as much as 80%. No negative peak was observed on the 
proton-saturated spectrum except for the peaks from side chains of amino acids. 
Among the assigned peaks, residues at the very N-terminal end (such as Ser2) as well 
as some His-tag residues (not labelled out) were found to exhibit a significant 
reduction in peak intensity compared to other residues. Peaks without backbone 
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assignment were found to have greater reduction in intensity as well, with some of 
them even becoming invisible. Taken together, these findings have suggested that the 
backbone assignment of EvpP_P143T harbours the rigid regions of EvpP which was 
found to be within the trypsin-digestion boundary. 
3.6.2 NOE pattern and possible secondary structure adopted by EvpP_P143T 




C-edited NOESY spectra. Sequential NOEs were observed for almost all assigned 
residues. Most dαN(i, i+1) NOEs were observed to have comparable or stronger signal 
intensities than the corresponding intra-residue dαN(i, i) NOEs. The dNN(i, i+1) NOEs 
were also observable for most assigned residues while medium range NOE could 
hardly be found (Figure 3.37). 
 
Figure 3.37, Sequential NOE pattern of EvpP_P143T. The relative signal intensities of 
dαN(i, i+1) and dNN(i, i+1) were depicted by the thickness of the black bars. The ratio between 
dαN(i, i) and dαN(i, i+1), as well as the ratio between dNN(i, i+1) and dαN(i, i+1) were also 
plotted against the sequence. 
 As shown in Figure 3.37, EvpP_P143T contains regions with extended 
backbone structure: S2 to N5, L34 to G43, I60 to D62, V73 to H78, V123 to F129 
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and L150 to Q152. In these regions, the intensity ratios of dαN(i, i)/dαN(i, i+1) were 
significantly less than 0.44 (typical for random coil structure). The ratios of dNN(i, 
i+1)/dαN(i, i+1) were also much less than 0.71 (typical for random coil structure) (Ma 
K, et al, 2001). Whether they form β-sheets requires further experiments to prove. 
However the NOE data agreed with the CD spectra that EvpP adopted β-like 
extended structure in certain regions rather than a totally random structure. In 
addition, no α-helices could be predicted. 
3.7 HDX-MS experiment of EvpP and its mutant P143T 
 Hydrogen-deuterium exchange mass spectrometry (HDX-MS) experiment 
provided another approach to probe the rigid as well as flexible regions of EvpP (and 
its mutant P143T). Both wild-type EvpP and the mutant P143T were used to carry out 
the experiments. Wild-type EvpP generated a library of 117 peptide fragments with 
99.5% sequence coverage while mutant P143T generated 119 of them, with sequence 
coverage of 98.9%. The dispersion of all the peptides among the sequence of EvpP 
(as well as P143T) was mapped by a shot-gun plot (Figure 3.38). A similar global 
pattern could be observed between EvpP and EvpP_P143T. In both proteins, peptides 
from the N-terminal half were usually longer while shorter peptides were found from 
the C-terminal half. Comparing EvpP with EvpP_P143T, it was obvious that 
EvpP_P143T had more longer peptides than wild-type EvpP. Particularly, at the site 
of mutation (residue 143), peptides from EvpP appeared to be more “fragmented” 
than those from EvpP_P143T. These findings have intuitively suggested that 
EvpP_P143T was more stable than EvpP towards complete proteolytic digestion by 
pepsin (the sample proteins were subjected to pepsin cleavage in the retention 
chamber for 3 minutes prior to the liquid chromatography followed by ESI-MS). 
Secondly, the N-terminal half was more protected from such digestion than the C-




Figure 3.38, Shot gun plots of all the observed peptides of EvpP and EvpP_P143T that 
were found to have decent signal intensities in DynamX. The complete sequence of wild 
type EvpP and EvpP_P143T were shown at bottom. Peptide fragments were mapped against 
respective protein sequences by green bars. 
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 To further characterize the H/D exchange patterns of EvpP and EvpP_P143T, 
a subset of peptides, spanning the entire protein sequence (with least overlapping 
residues), was chosen from each EvpP or EvpP_P143T peptide library to plot a “heat 
map”. The extent of deuteration for individual peptides was plotted in a time-
dependent manner, and the peptide was mapped onto the sequence of respective 
proteins to help visualize the global pattern. The criteria for choosing each subset of 
peptides were as follows:  
1. Subset A comprised of peptides having the highest signal intensities from 
the mass spectrum.  
2. Subset B comprised of peptides that were considerably short so that the 
heat map plotted by this subset would have a relatively higher “spatial 
resolution”.  
3. Subset C comprised of peptides that were chosen to fit the trypsin-
digestion boundary of EvpP or Evp_P143T.  
Heat maps plotted in the above 3 ways were shown in Figure 3.39 to 3.41. The heat 





Figure 3.39, Heat maps showing H/D exchange patterns of EvpP and EvpP mutant 
P143T. The peptides were chosen from subset A where they had highest signal intensities 
from respective mass spectra. Upper panel, heat map plotted for EvpP; Lower panel, heat map 







Figure 3.40, Heat maps showing H/D exchange patterns of EvpP and EvpP mutant 
P143T. The peptides were chosen from subset B where they were considerably short in order 
to construct a plot with relatively higher “spatial resolution”. Upper panel, heat map plotted 






Figure 3.41, Heat maps showing H/D exchange patterns of EvpP and EvpP mutant 
P143T. The peptides were chosen from subset C where they were tailored to the trypsin-
digestion boundary. Upper panel, heat map plotted for EvpP; Lower panel, heat map plotted 
for EvpP mutant P143T. 
 
 The three heat maps of EvpP demonstrated a coherent pattern of H/D 
exchange. Comparing these maps, the extensively-deuterated peptides all pointed to 
three convergent regions of EvpP, suggesting that these three regions would be 
considerably more flexible than their peripherals. The most flexible region was found 
to be from residue Leu87 to residue Ser104. This region underwent extensive H/D 
exchange (as much as more than 80% deuteration) in all heat maps. This is possibly 
because this was the linker region between the N-terminal 10-kDa piece and the C-
terminal 4-kDa piece marked by the trypsin-digestion boundary. A second flexible 
region was observed to start from residue Met135 to residue Thr149. Although EvpP 
was generally found to be flexible from residue Met135 all the way to residue Phe166; 
the fragment from Met135 to Thr149 appeared to be more flexible than its flanking 
residues. The third flexible region was found to be from residue Tyr47 to residue 
Ser54. This short stretch was found within the N-terminal trypsin digested boundary 
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of EvpP. Interestingly, residues from this region were also missing from the HSQC 
acquired for EvpP; since the assigned backbone of EvpP_P143T did not cover this 
region. However this region was not digested in limited proteolysis, possibly because 
it is short in amino acid sequence, making it inaccessible by various proteases. 
On the other hand, the heat maps also pointed to three rigid regions of EvpP. 
Firstly, a common pattern was observed in all heat maps plotted above. The N-
terminal half of EvpP had an overall HDX extent that was significantly lower than 
those in the flexible regions, especially in the initial time points (10 seconds, 20 
seconds and 30 seconds). A second distinctive rigid region came from residue Ser111 
to residue Phe132. This region matched our previous assignment on the 4-kDa piece 
of EvpP after limited trypsin digestion. Unexpectedly, the most rigid region 
throughout the entire EvpP sequence came from residues Ile119 to Tyr126, but not in 
the N-terminal half. The third rigid region was found to be from residue Tyr167 to 
residue Phe181. This was also to our surprise that the extent of deuteration was less 
than most of the N-terminal regions of EvpP. The presence of such rigid region could 
possibly be correlated to the presence of the three assigned residues at the C-terminus 
of EvpP. It was noticed that the C-terminal residues Val173 and Gly174 were having 
long range NOEs with residues Thr64 and Asp62. Residues flanking V173 and G174 
could also be interacting with residues near T64 and D62; or they could be interacting 
with residues from other rigid regions of EvpP, contributing to the tertiary structure. 
This might also explain why previously all the truncation mutants of EvpP were 
unstable and inevitably formed inclusion bodies. Unfortunately, only the C-terminal 
residues V173, G174 and H175 could be observed on the HSQC. Nevertheless, the 
rigid regions shown by the HDX-MS data further supported our previous hypothesis 
on the rigid regions of EvpP. It also helped to explain the presence of “VGH” on the 
HSQC even after trypsin digestion. 
 The heat maps of EvpP_P143T also pointed to three flexible regions 
coherently. Similar to EvpP, the most flexible region was found to come from 
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residues Leu87 to Leu102. Again this was within the linker between the two pieces 
coming out of limited trypsin digestion. The second flexible region was found at the 
N-terminal half, from residues Tyr47 to Leu55. This was the same as the third 
flexible region observed in wild-type EvpP. The third flexible region was found to 
come from residues Glu151 to Phe166. This was different from wild-type EvpP, as 
the same peptide in the latter was found to be less flexible than its preceding regions 
(from Met135 to Thr149). Therefore a significant change could be observed between 
wild-type and mutant EvpP. The region around the mutation point (Residue 143) has 
become less flexible due to the change of a single amino acid, from proline to 
threonine. This change could possibly be the reason why the mutant P143T was 
found to be more stable than wild-type EvpP. 
 Similar to wild-type EvpP, the rigid regions of the mutant P143T also 
converged to the same locations. The most rigid region of EvpP_P143T was found to 
come from residues Ile119 to Tyr126. The second rigid region was found at the C-
terminus, from residues Pro169 to Asn180. Again this was the same as wild-type 
EvpP. Nevertheless, the entire N-terminal half had a lower extent of H/D exchange 
compared to the flexible regions. 
3.7.1 Comparison between wild-type and mutant EvpP by HDX-MS revealed 
the major regions stabilized by the mutation P143T 
 By comparing the heat maps of wild-type EvpP with those of mutant P143T, 
it was noticed that the mutant P143T underwent less H/D exchange than wild-type 
EvpP. To systematically characterize the difference between EvpP and its mutant, a 
horizontal comparison between wild-type EvpP and EvpP_P143T was conducted 
using the two peptide libraries generated by HDX-MS. The two were compared 
against each other in search for common peptides that were present in both libraries. 
As a result, a total of 51 common peptides were identified. The differences in the 
extent of HDX for these peptides at various time-points were determined by 
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subtracting the HDX extent of wild-type EvpP’s peptides from that of EvpP_P143T. 
The results were then plotted into a difference plot (Figure 3.42). A positive number 
indicates that this peptide undergoes less H/D exchange in mutant P143T than in 
wild-type EvpP, which further implies a decrease in the flexibility of the peptide’s 
backbone in that particular region. 
 
Figure 3.42, Difference plot generated for all 51 common peptides between wild type 
EvpP and its mutant P143T.  
 
 As shown by figure 3.42, four distinct peptides of P143T were identified to 
have a considerably decreased extent of H/D exchange compared to wild-type EvpP. 
The four peptides were mapped onto EvpP_P143T sequence in Figure 3.43. 
 
Figure 3.43, Sequence of EvpP_P143T with the two stabilized peptides mapped out in 
blue; the trypsin-digestion boundary was marked by red box. 
 
 Peptide A was found to come from residues Tyr47 to Leu56. This region was 
located within the N-terminal half of EvpP; however this stretch of residues did not 
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show up on the HSQC. The decrease in its flexibility might be coming from a tertiary 
fold of EvpP where these residues could interact with residues from the mutation 
point. Such a global fold of EvpP was also supposed to protect region A from limited 
proteolysis. Peptides B and C were found within the linker region between the N-
terminal half and the 4-kDa piece. Peptide B ranged from residues Leu87 to Leu102 
while peptide C was from Met96 to Ser104, with seven overlapping residues. All the 
above three regions were considered to be flexible in EvpP. Therefore, a decreased 
flexibility in these regions might suggest possible interactions among different 
flexible regions. The last peptide was found to be within a relatively rigid region of 
EvpP, ranging from residue Ala127 to Phe132, which was located within the 
proximity of the mutation point. 
3.8 Interaction studies between EvpP and EvpC 
 It has been suggested by Zheng and Leung that EvpP may interact with EvpC 
(Zheng and Leung, 2007). To further characterize this interaction, we performed 
glutathione-S-transferase pull-down assay using GST-tagged EvpC with EvpP and its 














In each of the experiment, an internal GST-control was included. 
 
 As shown in Figure 3.44, GST-tagged EvpC was able to pull down both 
EvpP and refolded EvpP
1-168




was also unable to 
interact with GST-tagged EvpC (data not shown). Thus, the C-terminal flexible 
regions appeared to be involved in interaction with EvpC. The refolded protein 
EvpP
1-168
, although unstable, was still able to interact with EvpC to a comparable 
extent as in wild-type EvpP. However further removing the flexible regions greatly 





could not interact with GST-EvpC at all, due to the combined 
effect of removing the C-terminal flexible regions and the 4-kDa rigid region of EvpP. 
We’ve also attempted to sub-clone and express GST-tagged EvpP; but this construct 
of EvpP formed extensive inclusion bodies (data not shown). 
 To further elucidate the stoichiometry of interaction between EvpC and EvpP, 
we performed NMR titration experiment using non-labelled GST-tagged EvpC with 
15
N-edited EvpP. Both GST-EvpC and EvpP were concentrated to 750 µM 
respectively before they were mixed (in various proportions) together with NMR 
buffer to generated different ratios between EvpP and GST-EvpC (1: 0.2, 1: 0.4, 1: 
0.6, 1: 0.8, 1: 1 and 1: 2). The concentration of 
15
N-edited EvpP was kept constant at 




N HSQC spectra of EvpP 






Figure 3.45, NMR titration experiments of 
15
N-edited EvpP with different ratios of GST-
EvpC. Panel A, EvpP : GST-EvpC = 1 : 0.2; Panel B, 1 : 0.4; Panel C, 1 : 0.6; Panel D, 1 : 0.8; 
Panel E, 1 : 1; Panel F, 1 : 2. 
 
 As shown in Figure 3.45, the interaction between EvpP and GST-EvpC was 
demonstrated by the progressive decrease in peak intensities in a GST-EvpC 
concentration dependent manner. The binding of EvpP to GST-EvpC was observed to 
be saturated when the concentration ratio exceeded 1: 1. However we could not 
specifically deduce the individual residues that mediate such interaction. The 
decrease in peak intensity was global and progressive, suggesting that the 
disappearance of observable peaks on the HSQC was due to the general increase in 
molecular weight by binding to GST-EvpC, instead of the binding of a small region 
of EvpP to EvpC. Most of the peaks that remained observable on the HSQC even 
after saturation of interaction were found to be peaks from the histidine tag of EvpP. 
 We also performed the NMR titration experiments using non-labelled GST 
with 
15
N-edited EvpP as a control. The HSQC did not undergo any change even GST 
was titrated to a 1: 1 ratio with EvpP. Therefore, the observed interaction between 
GST-EvpC and EvpC was supposed to be mediated by EvpC and EvpP. 
Unexpectedly, his-tagged EvpC failed to interact with EvpP in both NMR titration 
99 
 
study as well as pull-down assays. One possible explanation could be that the 
oligomeric state of EvpC might be the important for the interaction to EvpP. GST-tag 
helps EvpC protein to adopt a dimer form, which could possibly be the pre-requisite 
for the interaction between EvpC and EvpP. 
 Lastly we performed protein cross-linking assay using EvpC with EvpP. 
EvpC was mixed with EvpP in a 1: 1 ratio at a concentration of 40 µM. The cross-
linking was catalysed by 2.3% glutaraldehyde at room temperature (Figure 3.46). 
 
Figure 3.46, Cross-linking assay using EvpC and EvpP. Lane 1, molecular weight marker; 
Lane 2 to Lane 7, cross-linking of EvpP and EvpC for different period of time. 
 
 
 As shown in Figure 3.46, EvpC was completely cross-linked within 10 
minutes of the experiment while only a small portion of EvpP was slowly cross-
linked to EvpC. As there was no observable dimer formation of EvpP (refer to Figure 
3.6 for the EvpP cross-linking assay), the gradual decrease in EvpP band intensity 
indicates possible cross-linking between EvpP and EvpC. This was not surprising as 
EvpC has been suggested to form hexamers at high concentration, or dimers at lower 
concentration. The intrinsic high propensity to form oligomers of EvpC might out-
compete its cross-linking with EvpP. We’ve also attempted to cross-link GST-tagged 
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EvpC together with EvpP; however the result was not conclusive. GST-tagged EvpC 
was soon cross-linked to each other while the cross-linking between EvpP and GST-
EvpC was not clearly observed (data not shown). 
 So far, only GST-tagged EvpC has been demonstrated to interact with EvpP 
in both NMR titration experiments and GST pull-down assay. EvpC alone could not 
induce significant perturbation in the HSQC of EvpP. The cross-linking assay did not 
show a clear pattern of interaction as well. In addition, the presence of a GST tag 
might further promote a dimer formation of EvpC. Whether this dimer formation has 




CHAPTER 4, RESULTS & DISCUSSIONS (AcrH-AopB) 
4.1 Elastase digested AcrH-AopB
1-264 
chaperone-translocator complex 
 Inside the Type III secretion system (T3SS) translocator operon of 
Aeromonas hydrophila, AopB and AopD were the two hydrophobic translocators that 
were found to be inserted into host cell membrane. The pore-forming ability of these 
proteins requires the presence of trans-membrane domains in their amino acid 
sequence. In order to prevent the pre-mature aggregation of AopB and AopD through 
their hydrophobic tans-membrane domains, a Class II chaperone AcrH binds to each 
of them; maintaining their stability before they become folded into a mature state. 
Tan Y W, et al, have laid the groundwork of the AcrH binding regions as well as their 
stoichiometry on AopB and AopD (Tan Y W, et al, 2009). Through limited protease 
digestion, the AcrH-binding regions of AopB and AopD have been mapped 
respectively. AopD binds AcrH using two discrete regions: DF1, from Val16 to 
Leu147 and DF2 from Ser242 to Phe296, as determined by digestion with 
chymotrypsin. AopB binds AcrH through one continuous region ranging from 
residues Ala33 to Leu264, as determined by digestion with elastase (Tan Y W, et al, 
2009). 
 It has been demonstrated by the same group that AcrH could be co-expressed 
and co-purified with either AopB or AopD. Particularly, full length AcrH could be 
co-expressed with a truncated form of AopB
1-264
. The purified chaperone-translocator 
complex went through limited protease digestion by elastase to reveal the AcrH-
binding region of AopB, from residue Ala33 to Leu264. Therefore we continued this 
research by exploring the possibility of crystalizing this partially digested protein 
complex. So far, no structure of Class II chaperone in complex with translocator has 
been reported yet. 
 We purified the partially digested complex of AcrH-AopB
33-264 
and set the 
crystallization screen using Hampton Crystal Screen I and II, Hampton Index Screen I 
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and II and Wizard Classic Crystallization Screen 1, 2, 3 and 4. Crystals formed in a 
few screening conditions (Figure 4.1), but they were all found to have very poor 




Figure 4.1, Crystals formed by the chaperone-translocator complex AcrH-AopB
33-264 
in 
different conditions. Panel A, crystals formed by AcrH-AopB
33-264 
in 1.4 M Sodium 
Potassium Phosphate pH6.9 at concentration of 12 mg/ml; Panel B, crystals formed by AcrH-
AopB
33-264 
0.1M HEPES Sodium pH7.5 with 1.5 M Lithium Sulfate Monohydrate at 




 As shown in Figure 4.1 B, another band beneath the AopB33-264 was 
observed from the protein crystal. This might imply that AopB33-264 has undergone 
degradation to a slightly shorter form. This shorter form would possibly be more 
stable than the one bound by elastase digestion. This, in turn, prompted us to explore 
other enzymes for limited proteolysis that could generate shorter boundaries on AopB, 
since the presence of flexible terminal residues may interfere with the quality of 
crystal packing. 
4.2 Limited proteolysis by thrombin yielded a stable complex in which AopB 
was slightly shorter 
 In order to optimize the boundary for limited protease digestion, several 
enzymes were tested to partially digest AcrH-AopB
1-264
. Among them, thrombin was 
identified to repeatedly produce a comparable digestion pattern to that of elastase. 
However, with thrombin, the digested AopB was found to be slightly shorter (Figure 
4.2). 
 
Figure 4.2, Limited protease digestion of AcrH-AopB
1-264 
by elastase and thrombin. Lane 
1, undigested AcrH-AopB
1-264
; Lane 2 to Lane 5, AcrH-AopB
1-264 
digested by elastase for 5 
min, 15 min, 30 min and 60 min; Lane 6, molecular weight marker; Lane 7, undigested AcrH-
AopB
1-264
; Lane 8 to Lane 11, AcrH-AopB
1-264
 digested by thrombin for 5 min, 15 min, 30 




 As shown in Figure 4.2, both elastase and thrombin were able to finish 
digestion within 30 minutes. In both cases, AcrH remained intact while AopB
1-264 
was 
digested to generate shorter fragments. The patterns yielded by both enzymes were 
similar, whereas AopB in thrombin digestion was observed to have slightly lower 
molecular weight than that of elastase digestion. The thrombin digested complex was 
able to be co-purified through FPLC. The elution profile suggested that they were 
also forming monomers (Figure 4.3). 
 
Figure 4.3, FPLC profile of AcrH-AopB
41-264 
complex (digested by thrombin). The 
complex was eluted out at 80 minutes through a Hiload Superdex200 size exclusion column. 
 
 Therefore we performed N-terminal sequencing using thrombin digested 
AcrH-AopB
1-264
. Thrombin digested protein bands were first immuno-blotted onto a 
PVDF membrane before being visualized by coomassie blue staining. The 
corresponding band of thrombin digested AopB was separated out and subjected to 
protein sequencing. As a result, an N-terminal residue stretch “VEKHGQGV” was 
unambiguously identified, matching the sequence of AopB from residues Val41 to 
Val48. This new boundary was eight residues shorter than the one generated by 
elastase. As the thrombin digested AcrH-AopB
41-264 
complex was stable and 
reproducible, we continued our crystallization screen using this new complex using 
the same screening kits as described above. Initial crystals were subjected to buffer 
and additive optimization. As expected, better crystals formed in a few buffer 
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conditions. However the best crystal from AcrH-AopB
41-264 
could only diffract to 7 Å 




Figure 4.4, Crystals formed by AcrH-AopB41-264 (digested by thrombin). Upper left, 
crystals formed by AcrH-AopB
41-264
 in 100 mM MES pH6.0 with 1.26 M Ammonium Sulfate; 
Upper right, crystal formed by AcrH-AopB
41-264
 in 100 mM Cacodylate pH6.5 with 1.26 M 
Ammonium Sulfate; Bottom, diffraction pattern of the crystal shown in the upper right panel. 
 
4.3 An even shorter boundary of AopB failed to yield better crystal 
 By shortening the digested boundary of AopB, the quality of resultant 
crystals could be improved. Therefore, we continued our work in seeking for even 
shorter boundaries on AopB digestion. Thrombin digested AcrH-AopB
41-264 
was used 
as the baseline. Various enzymes, such as trypsin, chymotrypsin, thermolysin, 
actinase E, proteinase K, clostripain and bromelain, were tested to further digest this 
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complex. Among these enzymes, thermolysin and actinase E generated relatively 




(generated through limited proteolysis by thrombin followed 
by purification through FPLC) digested by thermolysin in different concentration ratios. 
Lane 1, molecular weight marker; Lane 2, AcrH-AopB
41-264
, previously purified from 
thrombin digestion; Lane 3 to Lane 6, AcrH-AopB
41-264
 digested by thermolysin at a ratio of 
1:100 for 15 min, 30 min, 45 min and 60 min; Lane 7 to Lane 10, AcrH-AopB
41-264
 digested 




(generated through limited proteolysis by thrombin followed 
by purification through FPLC) digested by actinase E at a ratio of 1:100. Lane 1, 
molecular weight marker; Lane 2 to Lane 5, AcrH-AopB
41-264
 digested by actinase E for 15 
min, 30 min, 45 min and 60 min. 
 
 Thermolysin and actinase E were able to further cleave AcrH-AopB
41-264
 to 
generate a much shorter fragment of AopB. We subsequently performed N-terminal 
sequencing for the digested AopB in both cases. As expected, the digested AopB 
fragments were found to be the same between these two enzymes. The protein 
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sequencing results showed that AopB digested by either of these two enzymes had an 
N-terminal sequence of “MSPP” which matched the sequence of AopB from residue 
Met61 to Pro64 (Figure 4.7). It was intriguing to test out this new boundary in terms 
of crystallization. One thing we noticed was that thermolysin and actinase E were 
only able to cleave previously thrombin-digested AcrH-AopB
41-264 
complex to 
generate such shorter fragments. We’ve attempted to use these two enzymes to digest 
AcrH-AopB
1-264
, but they could not generate the above patterns. 
 As shown in Figures 4.5 and 4.6, apart from AopB, AcrH also underwent 
limited proteolysis by these two enzymes. We performed N-terminal sequencing for 
the digested AcrH and found that it had an N-terminal sequence of “MEHD”, which 
matched residues from Met1 to Asp4. This suggested that the partial digestion on 
AcrH happened at the C-terminal end. 
 
Figure 4.7, Sequence of the first 80 residues of AopB shown with the predicted secondary 
structure. The limited protease digestion boundaries on AopB were marked out. 
 
 Although thermolysin and actinase E were able to further digest AcrH-
AopB
41-264
, neither of them could achieve a complete partial digestion. In both cases, 
undigested AopB and AcrH were still observed in a significant amount compared to 
the digested ones. Apparently, thermolysin was more efficient in digesting AcrH as 
shown in Figure 4.5, Lane 6 and Lane 10. Complete digestion of AcrH could be 
achieved by thermolysin digestion in 60 minutes. On the other hand, actinase E was 
more efficient in digesting AopB. As shown in Figure 4.6, Lane 5, almost all AopB 
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have been digested to the shorter form. Therefore, to get a pure complete form of 
AcrH∆C-AopB
61-264
, three enzymes (thrombin, thermolysin and actinase E) were used 
to digest the complex in a sequential manner. First the undigested AcrH-AopB
1-264 
was digested by thrombin followed by FPLC purification to yield a pure form of 
AcrH-AopB
41-264
. This complex was then digested by thermolysin for 40 minutes. 10 
mM EDTA was added to partially inhibit the activity of thermolysin before the 
complex was further digested by actinase E for another 20 minutes in order to 
minimize over-digestion (Figure 4.8). 
 
Figure 4.8, Limited protease digestion of AcrH-AopB
41-264 
by a sequential digestion of 
thermolysin followed by actinase E. Lane 1, molecular weight marker; Lane 2, purified 
AcrH-AopB
41-264 
digested by thermolysin for 40 minutes; Lane 3 to Lane 8, thermolysin-
digested AcrH-AopB
41-264 
further digested by actinase E for different period of time: 5 min, 10 
min, 15 min, 20 min, 25 min and 30 min. 
 
 Using this method, we were able to get a relatively complete partial digestion 
for both AcrH and AopB to get the complex AcrH∆C-AopB
61-264
. However as shown 
in Figure 4.8, over-digestion occurred inevitably. The over-digested impurities could 
not be separated from size exclusion chromatography. Ion exchange chromatography 
helped in removing most of the over-digested products; however we still could not 
get a highly pure form of the AcrH∆C-AopB
61-264
 (Figure 4.9). 
 Nevertheless, we attempted to crystalize the triple-digested complex with the 
shortest form of AopB. Although crystals could form; the quality was not as good as 
those coming from limited proteolysis solely by thrombin (Figure 4.10). The presence 
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Figure 4.9, Ion exchange chromatography of triple-digested AcrH∆C-AopB
61-264
 complex 
at pH9. The elution gradient was set to be shallow however both AcrH-AopB complex as 




Figure 4.10, Crystals formed by the triple-digested AcrH∆C-AopB
61-264
. The quality was 




CHAPTER 5, CONCLUSION & FUTURE WORK 
5.1 EvpP in T6SS of Edwardsiella tarda 
 Edwardsiella tarda is one of the major fish pathogens with a wide range of 
hosts. Both T3SS and T6SS were identified in E. tarda that greatly contribute to 
virulence. Cross-talk between T3SS and T6SS mainly occurred at the transcription 
level (Leung K Y, et al, 2011). While T3SS is one of the most-studied secretion 
systems; the mystery of T6SS remains largely unraveled. Particularly in E. tarda, the 
T6SS gene cluster harbours a novel protein EvpP, which is not found in species 
outside the genus Edwardsiella. Previous study has demonstrated that EvpP plays an 
important role in virulence towards various hosts. Deletion mutation in the gene evpP 
significantly attenuated its virulence towards blue gourami fish (Zheng and Leung, 
2007), and was associated with retarded activity in hemolysis as well as 
internalization during the process of invasion (Xin W, et al, 2009). So far, little has 
been discovered about this unique protein EvpP, especially at the protein level. 
 Therefore, we attempted to gain structural insights into EvpP by mapping out 
its rigid and flexible regions. On the whole, EvpP is characterized to be a non-stable 
protein without a well-folded three-dimensional structure. More than half of the 
protein is predicted to be disordered. However, EvpP does have higher order 
structures as shown by its HSQC. Three approaches were adopted to map its rigid and 
flexible regions: limited protease digestion, NMR backbone assignment and HDX-
MS experiments. 
 Limited protease digestion has shown a coherent pattern that the N-terminal 
half is more rigid than the C-terminal half. The trypsin-digested pattern further 
suggested another rigid region of a 4-kDa piece in the C-terminal half of EvpP. This 
is validated by the relatively complete assignment of the peaks on the HSQC using a 
stable mutant of EvpP_P143T. As expected, more than 90% of the assigned peaks 
were found to be within the trypsin-digestion boundary, while most of them were 
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assigned to the N-terminal half of EvpP. In addition, the backbone assignment has 
suggested a third rigid region, possibly near the C-terminal end, where two out of 
three assigned residues were found to have long-range NOEs with residues from the 
N-terminal half, namely Val173 with Thr64 and Gly174 with Asp62. Such interaction 
could be strong as the Cα and Cβ chemical shifts of the C-terminal residues deviated 
largely from the values observed in a random coil. The presence of a C-terminal rigid 
region was further supported by the HDX-MS experiments. In both experiments 
using wild-type EvpP as well as mutant EvpP_P143T, a C-terminal rigid region with 
little H/D exchange was observed. Heat maps plotted using either wild type or mutant 
EvpP demonstrated that the linker region between the N-terminal half and the 4-kDa 
piece was the most flexible region throughout entire protein. In addition, it further 
pointed to another short region inside the N-terminal half of EvpP, which had 
relatively higher flexibility than its surroundings, coming from residues Tyr47 to 
Ser55. Interestingly, this region also matched the only gap of backbone assignment 
found in the N-terminal half of EvpP. However, this flexible region was not digested 
by limited proteolysis, most likely because this region is not extensively flexible 
enough to be accessible by various proteases.  
The major regions that were “stabilized” by the point mutation P143T was 
revealed by a comparison between wild-type EvpP and mutant EvpP_P143T in their 
extent of H/D exchange. The mutant P143T was found to stabilize three major 
regions of EvpP. The first region was the internal flexible gap in the N-terminal half 
that lacked backbone assignment. The second region was the linker that was found to 
be the most flexible region. A third region was a relatively rigid region near the 
mutation site. The stabilization by P143T in the flexible regions might imply potential 
interaction among flexible regions of EvpP. The general topologies of rigid and 




Figure 5.1, Sequence of EvpP with rigid and flexible regions mapped out. Rigid regions 
were highlighted in pink while flexible regions were highlighted in grey. The potential region 
which might be involved in interaction with EvpC was boxed. 
 
 EvpP has been suggested to bind EvpC (Zheng and Leung, 2007). We further 
examined this interaction by GST pull-down assay, NMR titration experiments and 
protein cross-linking assay. EvpC was shown to interact with EvpP in both pull down 
assay and NMR titration experiments. In both cases, the presence of the GST tag was 
required for successful interaction, while the GST protein alone failed to interact with 
EvpP at all. Thus, the observed interaction was supposed to be mediated between 
EvpC and EvpP. A C-terminal truncation mutant EvpP
1-168 
was shown to be able to 
interact with GST-EvpC, while a further truncation mutant EvpP
1-142 
largely abolished 
such interaction. Although both proteins were refolded from inclusion bodies with a 
low stability, they nevertheless led to the speculation of a role in binding EvpC for 
the C-terminal flexible regions (as marked in Figure 5.1). Intrinsic disordered regions 
are widely identified in proteins from T3SS, where they are demonstrated to play 
important roles in mediating protein-protein interaction (Lilic, et al, 2006 and 
Anastasia D, et al, 2009). The flexible regions of EvpP could also be the key to 
interaction activities with other members of T6SS, or even host cell entities. 
5.2 Future works on EvpP 
 One obvious goal is to solve the tertiary structure of EvpP, although this may 
require other molecules to further stabilize EvpP. As EvpP failed to crystalize and 
only a subset of residues showed up on HSQC of NMR experiments the 
determination of tertiary structure using native EvpP was proven to be challenging. 
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This may rely on the identification of novel interacting partners. EvpC is a reasonable 
candidate; however the interaction between EvpP and EvpC still remains elusive. 
While EvpP requires an interacting partner that can largely alter the flexibility in 
those regions before it can be completely stabilized, finding such binding partners is 
also challenging. But still, as disordered regions are commonly found to be mediating 
interaction activities in T3SS, stabilization in flexible regions of EvpP might help us 
determine the tertiary structure of EvpP, possibly in complex with its interacting 
partner. 
 Another interesting line of research on EvpP is to study the localization after 
being secreted via T6SS. EvpP has been proposed to be an effector protein, as it is 
secreted and it contributes to virulence. Whether EvpP gets injected into host cells 
seems to be an intriguing target. If so, its subcellular location as well as its interacting 
host cell entities will be of great research interest, which may further lead to alteration 
of host cell signaling. So far, the function studies on EvpP are solely based on 
deletion mutation together with complementation. The mechanism of such an activity 
still remains unraveled. 
5.3 AcrH-AopB in T3SS of Aeromonas hydrophila 
 Aeromonas hydrophila is another major pathogen to fish and sometimes 
humans. The presence of functional Type 3 and Type 6 secretion systems are also 
found to be the major components for its virulence. In A. hydrophila, two groups of 
proteins are secreted by the T3SS injectisome, effectors and translocators. In order to 
directly deliver effector proteins into host cell cytosol, translocator proteins AopB 
and AopD, with pore-forming ability, have to be inserted into the host cell membrane. 
They can then oligomerize to form a continuous channel connecting to the needle 
complex protruding out from the bacterial membrane (Neyt and Cornelis, 1999; 
Goure et al, 2005; Yu HB, et al, 2004). Translocator proteins are generally large and 
have trans-membrane domains. Therefore, genes encoding Class II chaperones are 
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generally located within the proximity of translocators. Class I chaperones bind to 
effectors while Class III chaperones bind to apparatus proteins. The structure of both 
Class I and Class III chaperones have been determined in complex with respective 
partners. However, no complex structure of a Class II chaperone with a translocator 
has been reported. In the translocator operon of A. hydrophila, AcrH is the chaperone 
for both translocators AopB and AopD. Tan Y W, et al, have demonstrated that AcrH 
forms 1:1 complex with either AopB or AopD. They also mapped the AcrH-binding 
regions on AopB and AopD (Tan Y W, et al, 2009). 
 Of our particular interest is the chaperone-translocator complex formed 
between AcrH and AopB, because the complex can be co-expressed and co-purified. 
We continued the research on AcrH-AopB complex starting from the elastase 
digested boundary (Tan Y W, et al, 2009). AcrH-AopB
1-264 
was digested by elastase 
and the resultant AcrH-AopB
33-264
 complex was purified for crystallization screen. 
Although crystals could form, they had poor diffraction. As a result, we attempted to 
optimize the limited proteolytic boundary of AcrH-AopB for complex crystallization. 
Limited proteolysis by thrombin generated a very close pattern to elastase. AopB was 
found to be digested to yield a shorter fragment from residues Val41 to Leu264. We 
subsequently subjected this new complex to crystallization screen. Better crystals 
formed by the complex AcrH-AopB
41-264
, with the best one able to diffract to 7.5 Å. 
This indicated that residues between Ala33 and Val41 were not involved in binding 
AcrH. Therefore, by reducing the flexible residues, we were able to improve the 
quality of AcrH-AopB complex slightly. In an attempt to further shorten the boundary 
on AopB, both thermolysin and actinase E were found to generate a coherent 
fragment of AopB that was 20 residues shorter than the one digested by thrombin, 
from residues Met61 to Leu264. This even shorter fragment of AopB was still able to 
bind AcrH tightly as they could be co-purified through either size exclusion or ion 
exchange chromatography. We further optimized the digestion protocol to get all 





complexes were digested by thrombin and purified to 
get a homogenous form of AcrH-AopB
41-264
. The complex was then digested by 
thermolysin for 40 minutes before being partially inhibited by 10 mM EDTA. 





as possible while keeping over-digested products at 
minimum. The triple-digested complex was then purified through ion exchange 
chromatography (MonoQ) at pH9.  However we failed to attain a highly pure form of 
this complex AcrH∆C-AopB
61-264
. The presence of impurities coming from over-
digested product severely interfered with the crystal formation of AcrH∆C-AopB
61-264
. 
Therefore, the best crystal still came from the one digested by thrombin. 
 By optimizing the boundaries for limited protease digestion alone, we could 
not obtain a high quality crystal from which the structure of the complex could be 
determined. The shorter fragments generated by different enzyme on AopB inevitably 
suggested a shorter binding region on AcrH. As shown in Figure 4.7, the N-terminal 
63 residues of AopB were predicted to be a disordered region. With limited 
proteolysis using various enzymes, we’ve demonstrated that the N-terminal 
disordered region was not involved in the binding of its chaperone AcrH. AopB
61-264 
was still able to bind AcrH tightly. As a result, the AcrH-binding domain of AopB 
might solely lie within the α-helical regions depicted in the secondary structure 
prediction. The N-terminal disordered region might have a completely different 
function other than being partially involved in binding AcrH. 
5.4 Future works on AcrH-AopB 
 The first obvious goal is to further optimize the AcrH-AopB complex to yield 
a high quality crystal, from which the three-dimensional structure of a Class II 
chaperone in complex with a translocator could be determined for the first time. This 
can be performed either by limited protease digestion with more enzymes, or by 
engineering an internal enzymatic cleavage site on AopB that is deeper inside the 
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thrombin cleavage site. As thrombin was demonstrated to stably digest AopB without 
much over-digested products, an internal thrombin cleavage site on AopB could be 
one possible choice. After we manage to acquire the structure of the AcrH-AopB 
chaperone-translocator complex, the detailed mechanism of interaction could be 
investigated accordingly. 
 Another approach is to co-express the AcrH∆C-AopB
1-264
 chaperone-
translocator complex and optimize from this new construct. Thermolysin and actinase 
E have been shown to digest a few residues at the C-terminal end of AcrH, and the 
remaining AcrH∆C still binds AopB strongly. We could possibly map out the 
remaining boundary on AcrH first and co-express this truncation mutant of AcrH 
together with AopB
1-264
. In addition, the C-terminal residues of AcrH are not involved 
in the formation of tetratricopeptide repeats. Therefore, this truncation most likely 
will not affect the interaction between AcrH and AopB. In this manner, we no longer 
need to consider whether the digestion of AcrH is complete, but only focus on the 
digestion of AopB.  
 Apart from AopB, the complex formed between AcrH and AopD is also an 
interesting target. Tan Y W, et al, have demonstrated that AcrH, AopB and AopD 
were able to form a metastable complex together (Tan Y W, et al, 2009). As a result, 
AcrH has to interact with AopB and AopD through different regions. It has been 
shown that the Class III chaperone YscG binds YscF and YscE simultaneously. The 
apparatus protein YscF binds the concave region of the chaperone YscG while YscE 
binds the convex (Sun P, et al, 2007). YscG is a chaperone with tetratricopeptide 
repeat domain that is similar to the Class II chaperone AcrH. Therefore it is also of 
great interest to find out how AcrH interacts with both translocator proteins AopB 
and AopD. 
 AcrH could be co-expressed with AopB or AopD. We can purify these two 
chaperone-translocator complexes separately and perform HDX-MS to map out the 
binding regions on AcrH by comparing the HDX pattern of AcrH alone with either 
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AcrH-AopB or AcrH-AopD complexes. The results could be compared horizontally 
to find out whether there’s any overlap between AopB and AopD binding regions on 
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Recipe for M9 medium 
 
To 773 ml of sterile water, add the following: 
 
200 ml   5X M9 
2 ml   1M MgSO4 
5 ml   20% Glucose 
0.1 ml   1M CaCl2 
4 ml   0.25 g/ml NH4Cl 




1.   5X M9 
 
30 g   Na2HPO4 
15 g   KH2PO4 
 2.5 g   NaCl 
 Add water to 1L 
 (Autoclave) 
 
2.   0.25 g/ml NH4Cl 
 
 50 g  NH4Cl, add water to 200 ml 




3.   20% Glucose 
 
 40 g  Glucose, add water to 200 ml 




4.   1M MgSO4 
 
 19.72 g MgSO4, add water to 80 ml 
 (Autoclave) 
 
5  1M CaCl2 
 
 11.76 g CaCl2, add water to 80 ml 












Buffers for Ni-NTA Affinity Chromatography 
 
• Nickel binding buffer 
 
 5 mM   Immidazole 
 0.5 M   NaCl 
 20 mM  Tris pH 8.0 
 
• Elution Buffer 
 
 0.5 M   Immidazole 
 0.5 M   NaCl 
 20 mM   Tris pH 8.0 
 
• Strip Buffer 
 
 100 mM  EDTA pH 8.0 
 0.5 M   NaCl 
 20 mM  Tris pH 8.0 
 
• Ni-Charge buffer 
 
 50 mM  NiSO4 
 
 
Buffers for Glutathione-Sepharose Chromatography 
 
• Phosphate Buffer Saline (PBS) 
 
 140 mM  NaCl 
 2.7 mM  KCl 
 10 mM  Na2HPO4 
 1.8 mM  KH2PO4 
 
• GST Elution Buffer 
 
 50 mM  Tris-Cl pH 8.0 
 10 mM  L-Gluthathione (reduced) 
 
• Column Regeneration Buffer 1 
 0.1 M   Tris-Cl pH 9.0 
 0.5 M   NaCl 
 
• Column Regeneration Buffer 2 
 
 0.1 M  Sodium acetate pH 4.5 









Recipe for SDS-PAGE 
 15% Separating Gel 4% Stacking Gel 
 
30% Acrylamide/0.8% Bis 3.5 ml 
 
0.4 ml 
Resolving Buffer 1.75 ml - 
 
Stacking Buffer - 
 
0.75 ml 
10% SDS 70 μl 30 μl 




42 μl 30 μl 
 




1.    Acrylamide solution (30%, 0.8 % Bis) 
2.    Resolving gel buffer: 1.5 M Tris, pH 8.8 
 
 For 200 ml, 36.3 g of Tris adjust to pH 8.8 with HCl 
 
3.    Stacking gel buffer: 0.5 M Tris, pH 6.8 
 
 For 200 ml, 12.1 g Tris, adjust to pH 6.8 with HCl 
 
4.    10% Ammonium persulphate: 1 g Ammonium persulphate in 10 ml water 
5.    10X Tank buffer: for 2 liters 
 
 60 g Tris base 
 288g Glycine 
 200 ml 10% SDS solution 
 Add water to 2 liters 
 
6.    2X SDS gel sample buffer: for 50 ml 
 
 5 ml   Glycerol 
 6.25 ml  0.5 M Tris pH 6.8 
 12.5 ml  10% SDS 
 2.5 ml   β-mercaptoethanol 
 0.01 g   Bromophenol blue 
 Add water to 50 ml 
 
7.    Stain stock: 1% Coomassie Brilliant Blue G (Stir and filter) 
8.    Destaining solution: for 2 liters 
 
 140 ml  Acetic acid 
 100 ml  Methanol 
 Add water to 2 liters 
 
 
